High throughput screen for cells with high extracellular metabolite consumption--secretion rates using microfluidic droplets by Wang, Benjamin L. (Benjamin Lu chen)
High throughput screen for cells with high extracellular metabolite 
consumption/secretion rates using microfluidic droplets 
 
by 
Benjamin L. Wang 
 
B.S., Chemical Engineering 
Carnegie Mellon University, 1997 
 
Submitted to the Department of Chemical Engineering 
in partial fulfillment of the requirements for the degree of 
 
DOCTOR OF PHILOSOPHY IN CHEMICAL ENGINEERING 
 
at the 
 
MASSACHUSETTS INSTITUTE OF TECHNOLOGY 
 
May 2009 
 
© Massachusetts Institute of Technology 2009 
All Rights Reserved 
 
 
 
 
 
 
 
 
Signature of Author:           
Benjamin L. Wang 
Department of Chemical Engineering 
May 26, 2009 
 
 
Certified by:            
Gregory N. Stephanopoulos 
Professor of Chemical Engineering 
Thesis Supervisor 
 
Accepted by:            
William M. Deen 
Professor of Chemical Engineering 
Chairman, Committee for Graduate Students 
 
   2  
High throughput screen for cells with high extracellular metabolite 
consumption/secretion rates using microfluidic droplets 
by 
Benjamin L. Wang 
 
Submitted to the Department of Chemical Engineering on May 26, 2009 in partial fulfillment of 
the requirements for the degree of Doctor of Philosophy in Chemical Engineering 
 
ABSTRACT 
 
Metabolic engineering has contributed significantly to the improvement of strains for the 
industrial production of various compounds.  Traditionally, enzymatic steps closely associated 
with the product-forming pathway have been engineered to prune side reactions and eliminate 
kinetic bottlenecks.  Other, so-called distal genes may also impact production in a profound way 
due to (often unknown) kinetic and regulatory effects.  Inverse Metabolic Engineering (IME) 
emerged as an approach to identify such distal genetic factors.  IME employs combinatorial 
methods whereby libraries are constructed harboring random genomic variants of the host or 
other strains, cells with superior properties are selected, and genetic inserts impacting the 
superior phenotype are characterized.  While many strategies can be deployed in library 
construction, broad applicability of IME to strain improvement for overproduction of secreted 
metabolites is severely limited by the availability of high-throughput methods for selecting 
strains with significantly improved metabolite secretion or uptake rates.  As soon as a metabolite 
is secreted, its association with the cell that secreted it is lost. Thus, each clone must grow in a 
separate environment to allow for the measurement of clone-specific metabolite concentrations.  
Furthermore, since many mutant libraries are large (≥104 unique clones), a high throughput 
screening platform must be used to culture and measure each unique clone.  Traditional methods 
such as microwell plates for culturing and assaying can be utilized.  However, this method is 
laborious, expensive, and low-throughout.  Other selection systems have been developed which 
are very specialized for the metabolite of interest so it is difficult to apply these systems to other 
applications. 
Here, we will describe a flexible high throughput screening platform which utilizes 
microfluidics to encapsulate cells in monodisperse nanoliter aqueous droplets surrounded by an 
immiscible fluorinated oil phase.  This system contains integrated modules for cell culturing, 
measurement of an extracellular metabolite with a fluorescent enzymatic assay, and sorting.  To 
demonstrate the functionality and flexibility of this system, high xylose and glucose consuming 
Saccharomyces cerevisiae strains were enriched from mixtures of known strains.  These high 
consuming strains could be identified even in a cell population of 1 cell/104.  Several S. 
cerevisiae and Escherichia coli libraries were also screened in this system.  One of these libraries 
was a genomic DNA library which was screened for high xylose consumption, an important 
phenotype for the utilization of lignocellulosic feedstocks.  This library was constructed using 
DNA from an evolutionary engineered strain containing the Piromyces sp. E2 xylose isomerase 
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gene.  This library was transformed into the original unevolved strain to identify the beneficial 
mutations which occurred during the strain evolution.  After screening the library and analyzing 
the highest xylose consuming strain, we determined that multiple copies of the xylose isomerase 
gene was one of the genomic changes responsible for high xylose consumption.  This 
microfluidic screening system is general and has broad applications in strain selection for the 
overproduction of fuels, chemicals, and pharmaceuticals. 
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Chapter 1. BACKGROUND 
 
 
 
 
1.1. Metabolic Engineering 
Metabolic engineering is the directed improvement of product formation through the 
modification of specific biochemical reactions or the introduction of new ones through the use of 
recombinant DNA technology.  Metabolic engineering has been utilized by industry to design or 
optimize microorganisms which overproduce particular chemicals.  Products manufactured 
through metabolic engineering include drugs, enzymes, food, commodity chemicals, and fuels 
(K.E. Tyo, Wang, & Stephanopoulos, 2007). 
With the advent of recombinant DNA technology, biological products of chemical or 
medicinal value, which previously were isolated from plants or animals in low yield, could be 
produced in microorganisms at reduced cost by transferring the DNA, which encodes the 
enzymes for the desired reaction, into the new host cell.  While this great achievement made the 
commercial production of many compounds possible, it was quickly realized that high yields 
could only be realized in certain cases.  Metabolic engineering, as a discipline, looks beyond the 
enzyme that forms the final product, to understand how the rest of the cell behaves when this 
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new reaction is added.  Unless additional modifications are made, a cell normally regulates the 
reaction network to improve growth which can divert metabolites away from the reactions 
associated with the production of the target metabolite.  By understanding the cell’s metabolic 
reaction network, which is the complex set of chemical reactions that take place within the cell, 
reactions can be identified which could increase the output of the desired product.  This systems 
approach is necessary as the cell is very complex (Bailey, 1991; Stephanopoulos & Vallino, 
1991). 
Genetic changes can be made to the cell to increase or decrease the reaction rate of one or 
more steps in the metabolic network to greatly increase the yield of the desired product.  To 
increase the rate of a particular reaction, the enzyme catalyzing that reaction can be 
overexpressed on a plasmid.  The overexpression of the ppsA and tktA genes enhanced the 
availability of two precursor metabolites, phosphoenolpyruvate and erythrose-4-phosphate 
levels, in an Escherichia coli tyrosine producing strain improved the production levels by 79% 
(Lutke-Eversloh & Stephanopoulos, 2007).  Reactions can be eliminated by knocking out the 
associated enzyme.  For example, an in-silico stoichiometric model of the metabolic pathways in 
a cell was utilized to identify single, double, and triple gene knockouts to improve the lycopene 
production in a previously engineered strain of E. coli.  By incorporating these knockouts 
experimentally, the production improved by 37% (Alper, Jin, Moxley, & Stephanopoulos, 2005).  
Metabolic engineering has contributed significantly to the rational improvement of strains for 
industrial applications.  However, they are limited to making changes only to previously studied 
metabolic pathways (Alper, Miyaoku, & Stephanopoulos, 2005). 
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1.2. Inverse metabolic engineering 
An extension of metabolic engineering is inverse metabolic engineering (IME) (Bailey et 
al., 1996).  In contrast to classical metabolic engineering in which systematic changes are made 
to known genes which affect the metabolic pathway, IME allows for the evaluation of the effects 
of unknown or distal genes on an organism’s production capabilities.  Other genes, which may 
also impact production in a profound way due to (often unknown) kinetic and regulatory effects, 
can thus be identified by IME.  In this methodology, combinatorial libraries are constructed by 
incorporating random genomic variants into a host strain, cells with superior properties are 
selected from these libraries, and the specific genetic alteration is identified.  IME differs from 
classical strain improvement, which uses genetic libraries with cells containing random 
untraceable mutations.  Mutants identified using IME have traceable mutations that allow 
engineers to locate those mutations and endow them onto other cells.  There are several 
additional advantages for using IME.  Since the mutated gene is known using IME, the effect of 
the mutation can be confirmed by making the same mutation into a clean background of the 
parental strain.  The mutated gene is well-characterized so an organism with that mutation can 
confidently be used as the basis for producing higher producing organisms.  Companies can also 
patent the exact mutation so that they can have exclusive rights to produce specific metabolite at 
high titers. 
 
1.3. Combinatorial strategies for generation libraries 
Constructing the appropriate combinatorial libraries is an important part of inverse 
metabolic engineering, and many strategies have been developed for this purpose.  Critical genes 
in the pathway can be identified simply by creating overexpression or gene knockout libraries.  A 
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combination of aromatic amino acid biosynthesis genes were overexpressed in a library of less 
than 50 clones.  Since the size of this library was small, it was screened by culturing cells in 96 
well plates and using a colorimetric assay.  The selection process identified the overexpression of 
tyrB and ydiB, which encode for the enzymes which forms tyrosine and shikimate, respectively 
as the combination which increased the tyrosine concentrations by 26%.  Since this experiment 
only contained approximately 50 unique clones, the library was screened by culturing cells in 96 
well plates and using a colorimetric assay (Lutke-Eversloh & Stephanopoulos, 2008).  A 
significantly larger random knockout library was utilized to identify genes which when deleted 
would improve the production of tyrosine.  Since the number of clones was greater than 104, a 
screening system for tyrosine overproducing strains was developed where genes are added to the 
tyrosine producing cells converting tyrosine into a dark melanin pigment.  In this system, 
colonies were grown on agar plates and the ones in the darkest area of the plate were identified 
as the ones producing highest levels of tyrosine.  The highest tyrosine producers with the 
deletion of the ygdT gene, which has unknown function, produced 71% more tyrosine than the 
parental strain (Santos & Stephanopoulos, 2008). 
To fine-tune the expression of a particular gene, a library containing varying promoter 
strengths can be generated.  Typically, a gene is either only overexpressed or deleted.  However, 
in this case, the gene expression levels are only evaluated at a couple of discrete points.  If there 
is a global maximum in the promoter strength, there is an advantage to using a promoter library 
which contains a continuum of promoter strengths so that the optimal gene expression level can 
be determined.  A library was created which varied the promoter strength for dxs, a critical gene 
for the production an important precursor metabolite in the production of lycopene.  E. coli 
stores lycopene in the membrane and cells which have higher lycopene accumulation also have a 
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darker red color.  Thus, the library can be screened by growing the cells on agar plates and 
identifying higher producers by eye.  The maximum lycopene production occurred when using a 
medium promoter strength (Alper, Fischer, Nevoigt, & Stephanopoulos, 2005). 
If the phenotype of interest is complex, global transcription machinery engineering 
(gTME) allows for gene expression to be modified in multiple genes simultaneously through the 
use of global transcription regulator libraries (Alper, Moxley, Nevoigt, Fink, & Stephanopoulos, 
2006).  In gTME, diverse error-prone PCR libraries of proteins which affect DNA to RNA 
transcription are created and screened to find mutants with the most desired phenotype.  When 
investigating complex phenotypes, gTME can be a more useful tool than the traditional methods 
of deleting or overexpressing genes because the mutated factors can affect the transcription of 
more than one gene.  gTME has been used to find strains of yeast which had high ethanol 
tolerance and productivity through the use of a library of the spt15 gene which encodes for 
TATA-binding protein which binds to the TATA box sequence in DNA and initiates 
transcription (Alper, Moxley et al., 2006). 
 
1.4. High throughput screening 
While many strategies can be deployed in library construction, strain improvement is 
limited by what can be screened.  The simplest and most efficient screening strategies are those 
where serial subculturing can be used to select for cells with high growth rates or survival rates 
(Alper, Moxley et al., 2006).  Screening methods based on metabolite levels are more 
challenging because the appropriate metabolite measurement technique may not be adaptable to 
a high throughput screening system.  Metabolite screening technologies can be classified into 
two main groups depending on whether the metabolite of interest is intracellular or extracellular. 
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Developing an intracellular metabolite screen is typically easier to develop because there 
is a direct connection between a cell and the metabolite of interest.  One example of an 
interacellular metabolite screen is for the selection of E. coli lycopene overproducing strains 
which has already been described (Alper, Fischer, Nevoigt, & Stephanopoulos, 2006).  Another 
example is the selection of bacterial strains producing poly-3-hydroxybutyrate.  These organisms 
store the polymer internally so they can be stained with fluorescent Nile Red and high producers 
can be selected with a fluorescence-activated cell sorter (FACS) (K. E. Tyo, Zhou, & 
Stephanopoulos, 2006). 
For many metabolic engineering applications, the selection criterion is the production of 
a secreted metabolite or the consumption of a medium component.  Thus, extracellular 
metabolite levels must be quantified.  However, unlike intracellular metabolites, they have no 
natural association with the clone of interest.  Several extracellular metabolite screens have been 
reported.  The selection of high tyrosine consuming strains through the conversion of tyrosine to 
the dark pigment melanin has already been mentioned.  To select for high mevalonate producing 
strains from a library, cells were grown on agar plates with a lawn of mevalonate auxotrophic 
cells which produced green fluorescent protein (GFP).  Colonies from the library surrounded by 
green fluorescing cells were identified as high mevalonate producing strains.  Since these 
methods of screening libraries were developed to be metabolite-specific, other metabolites 
cannot be detected easily with the same type of system.  Ideally, one would use a flexible high 
throughput screening platform in which a single component in the assay system was metabolite-
specific so that when a different metabolite was to be screened in the system, only a substitution 
of that component would be necessary.  A strategy for compartmentalizing clones must be 
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utilized to ensure that each clone grows in a separate environment which allows for the 
measurement of clone-specific metabolite concentrations. 
Since libraries contain many unique clones, it is critical to use systems which can handle 
higher numbers of cultures than traditional culturing tubes, shake flasks, or bioreactors.  Such 
systems are generally parallelizable and can be used to compare different strains.  MicroReactor 
Technologies has developed 4-6mL miniature bioreactors which have dissolved oxygen and pH 
control using fluorescent sensor technology (Isett, George, Herber, & Amanullah, 2007; Tang, 
Laidlaw, Gani, & Keasling, 2006).  A microbioreactor system which can handle a much smaller 
250μL culturing volume was fabricated using printed circuit board technology and microplate 
strips to continuously measure the cell density and pH.  The initial system contained eight 
microreactors but could be easily expanded to handle higher numbers (Maharbiz, Holtz, Howe, 
& Keasling, 2004).  While these systems are called “high-throughput”, they still do not have the 
ability to screen an actual genetic library which contain ≥104 unique clones.  Thus, a true high 
throughput screening platform must be used to culture and measure every unique clone.  
Traditional methods such as microwell plates for culturing and assaying can be utilized but are 
not sufficiently high throughput unless robotic automation is utilized (Sonderegger, Schumperli, 
& Sauer, 2005).  Several true high throughput technologies which compartmentalize clones will 
be described. 
 
1.4.1. Gel microdroplet technology 
Gel microdroplet technology was developed to measure extracellular metabolite levels 
for individual cells (Gift, Park, Paradis, Demain, & Weaver, 1996; Weaver, Williams, Klibanov, 
& Demain, 1988).  In this system, cells are encapsulated into agarose gel droplets.  The gels are 
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created by stirring a mixture of cells, molten agar, and an emulsion liquid.  Then, nylon meshes 
are used as sieves to produce a narrower gel drop size distribution.  The culture conditions 
depend on the application.  The microdroplets can be suspended in culture medium, or the 
medium can be added during gel formation and cultured in a hydrocarbon oil to prevent the 
diffusion of hydrophilic compounds.  The assay chemicals can be added during gel formation or 
after culturing. 
In this system, cells are cultured in gel microdroplets which prevent or reduce the 
diffusion of chemicals away from the cell, and the use of the hydrocarbon oil can also serve as a 
barrier between different droplets.  However, the biggest drawback of this technology is that it 
produces gel containers which have large variations in size.  While the usage of sieves can 
improve the variation, the resulting distribution becomes non-Gaussian, and thus, the actual 
droplet variation is still large. 
 
1.4.2. Droplet emulsion technology 
Droplet emulsion technology also provides a method to compartmentalize clones by 
placing individual cells in aqueous droplets surrounded by an immiscible oil phase to form a 
water in oil (w/o) emulsion.  The oil phase contains a hydrocarbon, silicone, or fluorocarbon oil 
and an appropriate surfactant which allows for the formation and stabilization of the droplets.  
Initial fluorescence detection and sorting using this technology was performed on a fluorescence-
activated cell sorting (FACS) machine, but the outer oil phase damaged the sorter since it was 
not aqueous.  Later experiments were performed using a more complicated water in oil in water 
(w/o/w) double emulsion so that the FACS machines were still functional after use. 
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The main application of this system has been to increase the activity of enzymes from 
cells or in-vitro translation.  The cells or the in-vitro translation mixture were mixed with the 
corresponding assay chemicals and encapsulated in droplets.  After incubating the droplets for a 
predetermined amount of time to permit significant enzyme production and to also allow the 
assay reaction to proceed to completion, the high fluorescencing droplets were sorted using a 
FACS machine to identify the enzymes with the highest activity.  Traditionally the droplets have 
been created by using a homogenizer, but this process produces significant droplet volume 
variations.  Thus, only libraries with high library diversity can be screened.  In the directed 
evolution of enzymes, a single round of library construction and screening can typically improve 
the enzyme activity by several orders of magnitude (Aharoni, Amitai, Bernath, Magdassi, & 
Tawfik, 2005; Miller et al., 2006; Tawfik & Griffiths, 1998).   
 
1.5. Microfluidics for metabolic engineering applications 
Microfluidics is a technology in which small amounts of liquids (e.g., volumes of a 
nanoliter or less) can be manipulated for a variety of applications including analysis, reactions, 
and cell-based assays (Whitesides, 2006).  There are several advantages of using this type of 
system: (a) Microfluidic devices can handle small volumes which allows for increased 
measurement sensitivity.  Furthermore, traditional analytical equipment and reactors which use 
large volumes can be miniaturized.  Thus, a smaller amount of reagent chemicals is consumed 
with a drastic proportional reduction in the cost. (b) With the advent of microfluidic devices, 
manipulating single cells becomes possible so that the biological diversity of populations can be 
characterized (Weibel, DiLuzio, & Whitesides, 2007). (c) It is easy to quickly prototype devices 
which allows for a fast turnaround time when developing a new type of device. 
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Most microfluidic devices are fabricated through the use of poly(dimethylsiloxane) 
(PDMS) using the following steps (Figure 1.1).  First, a photomask, such as a transparency, is 
designed and generated with the desired channel pattern.  Then, through use of photolithography, 
UV light exposes photoresist on silicon wafer in areas which are not protected by the photomask.  
This exposure crosslinks the photoresist in those regions so that they are not rinsed off during the 
photodeveloping step.  This crosslinked photoresist on the silicon wafer becomes the master, 
which is a three dimensional stencil for the final device channels.  The master is placed into a 
container such as a petri dish and uncured PDMS is added.  After curing, the PDMS is removed 
from the dish and bonded to a glass slide.  This process allows for a high amount of flexibility 
and rapid protoyping.  The time from photomask design to device testing can be as short as a 
couple of days which means that the optimization of a device design can be a fairly expeditious 
endeavor (Ng, Gitlin, Stroock, & Whitesides, 2002). 
There has been much work to develop biochemical and biological tools using 
microfluidics.  Several systems with relevance to the metabolic engineering will be described 
further.  An automated microchemostat was created which had the ability to culture cells, add 
medium, and remove the culture solution as in a standard chemostat as well as to monitor the cell 
population.  The functionality of this system was demonstrated by growing and monitoring a 
strain which contained a synthetic biology circuit that produced oscillations in the overall 
population cell density (Balagadde, You, Hansen, Arnold, & Quake, 2005).  Optical tweezer 
technology has been integrated into a microfluidic device so that an incoming population with a 
low number of cells can be sorted with high yield.  Such a system has an advantage over 
standard flow activated cell sorting (FACS) machines which typically require a large initial cell 
count due to a lower overall yield (Wang et al., 2005). 
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Figure 1.1: The process of creating a microfluidic device: (A) A CAD file is created 
which contains the microfluidics device design.  This design is transferred to a 
photomask such as a transparency.  (B) This photomask only allows light to expose 
and crosslink the photoresist only in certain areas. The master is complete after 
dissolving the uncrosslinked resist.  (C) Uncured PDMS poured onto the master and 
peeled off after curing (Ng et al., 2002) 
 
1.6. Microfluidic droplet emulsion technology 
Microfluidics droplet emulsion technology generates droplet size distributions with 
variations of less than 3% (Link, Anna, Weitz, & Stone, 2004).  If the metabolite concentration is 
used as the metric for screening libraries, the variation of this metric across the library is 
typically small (e.g., less than a factor of two).  This means that a small droplet size variation is 
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critical for the success of a high throughput screening platform.  Droplet sizes of a nanoliter or 
less can be generated reproducibly in microfluidic systems which allows for high measurement 
sensitivity because the concentration changes inside the droplet are magnified.  Combining 
microfluidics and droplet emulsion technology also allows for droplets to be merged, analyzed, 
and sorted (Ahn, Agresti, Chong, Marquez, & Weitz, 2006; Ahn, Kerbage et al., 2006).  One 
goal of microfluidics research is to develop an integrated “lab-on-a-chip” or “micro-total-
analysis-system” which can perform both cell culturing, analysis, and cell manipulation in an 
integrated system (El-Ali, Sorger, & Jensen, 2006).  By integrating these microfluidic droplet 
manipulation modules together, a true “lab-on-a-chip” can be realized. 
In order to determine the feasibility of the device, a calculation was performed to 
determine how long cells would need to be cultured in order to consume detectable amounts of 
glucose.  To calculate the glucose consumed, the Equations 1.1-1.4 were used where X is the cell 
density, µ is the specific growth rate, t is the culture time, X0 is the initial cell density, C is the 
glucose concentration, C0 is the initial glucose concentration, and Qg is the specific glucose 
consumption rate. 
μ=∂
dX X
t
 Equation 1.1 
0 e
μ= tX X  Equation 1.2 
0 0 e
μ= = − tg gdC Q X C Q Xdt  Equation 1.3 
( )00 e 1μμ= − −g tQ XC C  Equation 1.4 
The differential equation for exponential growth in Equation 1.1 was solved analytically as 
Equation 1.2.  The value for the cell density was incorporated into Equation 1.3 and the resulting 
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differential equation was solved to create Equation 1.4.  In this calculation, there was initially a 
single cell in a 75µm droplet, and the cell was allowed to divide based on exponential growth.  
The specific growth rate was 0.25 hr-1, the initial cell density of one cell in a volume of 0.33nL 
can also be represented as 7.9pg/0.33nL = 0.24g/L.  The initial glucose concentration is 5g/L and 
the specific glucose consumption rate is 1.3 g glucose / (g cell × hr).  Figure 1.2 shows the 
results of this calculation where a single baker’s yeast cell in a 75μm diameter droplet will 
consume 2g/L of glucose from an produce 5mM ethanol within 4 hours which can easily be 
detected with a fluorescent assay. 
 
Figure 1.2: Calculated growth of cells and glucose consumption when 
starting from a single yeast cell in a 75μm droplet 
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1.7. Thesis Overview 
The objectives of this thesis are as follows: 
1. Determination of a general metabolite assay which is suitable for high throughput screening.  
The assay is an important component of a screening system.  Not only does it need to be fast 
but must be general enough to measure several metabolites with only small modifications. 
2. Development of a high throughput screening system for screening IME libraries.  The 
screening system must have sufficient speed to measure libraries which contain 104 unique 
clones. 
3. Testing the capabilities of high throughput screening system.  As a proof of concept, 
enrichment of a high consuming or producing strain from a known mixture demonstrates the 
functionality of a complete system.  A more challenging task is to screen actual libraries to 
select for high consuming or producing strains.  Using different organisms and measuring 
different metabolites shows that the platform is general. 
 
1.8. Thesis organization 
This thesis focuses on the construction of a high throughput screening platform using 
microfluidic droplet technology and its application for the selection of high xylose and glucose 
consuming yeast and bacterial strains.  Chapter 2 describes the microfluidic system, which is the 
basis of the screening platform, and the flexible metabolite assay which is a critical component 
of this system.  In Chapter 3, the functionality of this system is demonstrated through the study 
of xylose consuming yeast strains.  These results include the enrichment of a high xylose 
consuming strain from known mixtures of strains including a mixture where the incoming 
percentage of high consuming cells was similar to that found in a true library.  Several yeast 
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libraries were also screened including a gene shuffling library, a small library containing genes 
which could improve xylose utilization, and a genomic DNA library.  In Chapter 4, the 
enrichment of high glucose consuming strains is described in order to demonstrate how general 
this system is.  Chapter 5 describes the utilization of the screening system to identify high xylose 
consuming bacterial strains from gTME libraries of the rpoA and rpoD genes.  The work to 
detect ethanol in droplets is reported in Chapter 6 even though it was discovered that ethanol 
leaks out of the droplets.  The initial proposed assay for the high throughput screening system 
was the use of enzyme electrodes to measure amino acid concentrations.  The development of 
enzyme electrodes for the detection of tyrosine and aspartic acid is discussed in Chapter 7.  
However, these measurements were not sufficiently high throughput and were not integrated into 
a screening system.  Chapter 8 serves as the concluding chapter for this thesis where all of the 
work in thesis is summarized.  It also includes a discussion of the impact of this high throughput 
screening system and future work. 
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Chapter 2. HIGH THROUGHPUT SCREENING PLATFORM 
 
 
 
 
2.1. Introduction 
Strain improvement by combinatorial metabolic engineering for overproduction of 
secreted metabolites requires a high-throughput strain-selection system which maintains the 
association between the cell and the metabolites it secretes.  This is a challenge task because the 
cell-product association is severed as soon as the product is secreted.  Here, we present a flexible 
high-throughput screening platform which utilizes microfluidics to compartmentalize cells by 
encapsulating them in monodisperse nanoliter aqueous droplets surrounded by an immiscible 
fluorinated oil phase. 
 
2.2. System description 
This high throughput screening platform uses microfluidic droplet emulsion technology 
to select for strains from libraries created for inverse metabolic engineering applications.  It is an 
integrated system which has the capability to encapsulate yeast cells in monodisperse nanoliter 
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volume aqueous droplets surrounded by an immiscible fluorinated oil phase, culture the cells, 
mix the contents of the droplets containing cells with a fluorescent enzymatic assay, measure the 
resulting fluorescence, and sort droplets based on that measurement.  This work is the first to 
integrate droplet coalescence, fluorescence detection, and sorting into a single device. 
In this system, yeast cells in phosphate buffered saline (PBS) are initially mixed with cell 
culture medium.  Droplets are formed by combining this aqueous stream with two streams 
containing a fluorinated oil and surfactant mixture.  The 0.3nL droplets formed in this device are 
collected in a syringe which provides a microaerobic environment when capped.  The syringe is 
placed in an incubator for culturing.  After culturing for a predetermined amount of time, 
droplets from the incubated syringe are reinjected into a second device where they are combined 
with another set of droplets containing fluorescent enzymatic assay reagents.  After droplet 
coalescence, the resulting droplets flow through channels for 30 seconds to allow the assay 
reaction to proceed.  The extracellular concentration of the metabolite of interest is determined 
by measuring the droplet fluorescence with a laser/photomultiplier tube system.  Based on this 
measurement, the droplets are sorted into one of two channels.  This system as currently 
configured can screen approximately 1-2 clones per second so that 104 clones can be screened in 
less than 3 hours (Figure 2.1). 
This system was designed to have separate culturing and assay steps instead of 
performing both steps simultaneously because of several reasons.  First, it allows for the 
measurement of the consumption of medium components (e.g., sugars in the medium).  Cells can 
also be cultured in medium only as opposed to a mixture of the medium and the assay chemicals.  
Normally, cells are cultured with the medium only so this is more representative for the standard 
biological environment.  Anaerobic culturing can also be performed in this system even if the 
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assay system used needs oxygen.  Lastly, some assay chemicals may leak out of the droplet over 
the period of hours so performing a separate assay measurement which has a reaction time of 30 
seconds reduces the total amount of leakage to an undetectable level. 
 
 
Figure 2.1: Schematic of the microfluidic high throughput screening platform which can 
encapsulate cells and culture medium in droplets, culture the cells in droplets, add fluorescent 
assay reagents for the metabolite of interest to the cell-containing droplets, allow the assay 
reaction to proceed, and sort droplets based on the resulting fluorescence. 
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2.3. Materials and Methods 
2.3.1. Device fabrication 
Microfluidic devices were fabricated by using standard soft lithography techniques.  SU-
8 2025 and 2050 photoresists (MicroChem) were spin coated at either a 25 or 75µm thickness on 
3 inch test grade silicon wafers.  The channel pattern was photolithographically defined by a film 
mask printed at 20,000 dpi.  After developing the photoresist, poly(dimethylsiloxane) (Sylgard 
184 Silicone Elastomer Kit from Dow Chemical) in a 10:1 silicone to crosslinker ratio was 
poured onto the wafer.  After degassing for 10 minutes and curing overnight at 65ºC, the PDMS 
devices were cut from the mold and the inlets and outlets were formed with a biopsy punch.  The 
PDMS was bonded to a glass slide after exposure to an oxygen plasma.  The 2 inch × 3 inch 
glass slides for devices with electrodes contained an indium tin oxide coating (Delta 
Technologies) on the surface opposite the device.  Electrodes were made in the device using a 
procedure similar to the one described by Siegel et al. (Siegel, Bruzewicz, Weibel, & Whitesides, 
2007).  The electrode channels were first coated with 0.1M (3-Mercaptopropyl)trimethoxysilane 
(Sigma) dissolved in acetonitrile (Sigma) and afterwards air was blown to remove the solution.  
The device was then baked at 65ºC to remove any remaining solution.  When the device was 
placed on a hot plate at 80ºC, Indalloy 19 solder (52% In, 32.5% Bi, 16.5% Sn - 0.020 inch 
diameter wire from Indium Corporation) was placed in the electrode inlets and allowed to melt.  
Once the solder reached the outlets, 22 gauge wire was placed in the outlets to form an external 
electrical connection.  All other devices used uncoated 2 inch × 3 inch Swiss Glass slides.  
Before using the microfluidic devices, the PDMS channel surface was made hydrophobic by 
injecting Aquapel (PPG) into the channels.  Air was blown through the channels to remove the 
Aquapel. 
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2.3.2. Microfluidic device experimental setup 
All fluids were supplied to the microfluidic devices by syringes connected to NE-500 
(New Era) or PHD 2000 (Harvard Apparatus) syringe pumps with PE-20 (Intramedic) or PEEK 
(VICI Valco) tubing.  Proprietary fluorinated oil and surfactants were supplied by Raindance 
Technologies.  For non-emulsion inputs into the microfluidic device, PE-20 tubing (Intramedic) 
with a 0.015 inch inner diameter connected the syringes to the device.  To ensure that droplets 
from a reinjected emulsion did not coalesce in the tubing, TPK.515 PEEK tubing (Vici Valco) 
with a 0.015 inch inner diameter was used.  This tubing was also used to connect the outlet from 
the drop making device to the syringes used for cell incubation.  1mL unfiltered sterile pipet tips 
collected the emulsions in the “desired” and “undesired” channels from the sorting device.  To 
monitor the functionality of microfluidic device, an Ultima 512 (Photron) was connected to a 
Motic AE30 inverted microscope.  The coalescence electrodes were connected to a BXA-12579 
inverter (JKL Components Corporation) and DC power supply while the sorting electrodes were 
connected to a Model 609E-6 high voltage amplifier (TREK).  Fluorescence detection was 
performed using a 50mW 488nm laser (Picarro) for excitation and a photomultiplier tube 
(Hamamatsu) with a 593nm filter (Semrock).  Syringes were incubated in a Lab-Line compact 
incubator.  3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluoro-1-octanol was added to the sorted droplets in 
order to break the emulsion and allow for the isolation of cells for characterization or additional 
screening. 
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2.3.3. Fluorescent enzymatic assay 
The assay mixture contained phosphate buffered saline (PBS) (Mediatech), Amplex 
UltraRed (Invitrogen), horseradish peroxidase (Sigma), and the corresponding oxidase enzyme 
which reacts with the metabolite of interest.  The assay used to detect xylose contained pyranose 
oxidase (Sigma) at the appropriate concentration which ensures that the initial amount of xylose 
in the medium can be measured reliably, 0.4U/mL horseradish peroxidase, and 0.2mM Amplex 
UltraRed.  Glucose can be measured using glucose oxidase (Sigma) at the appropriate 
concentration which depends on the initial amount of glucose in the medium, 0.4U/mL 
horseradish peroxidase, and 0.2mM Amplex UltraRed.  Bovine serum albumin (BSA) (Sigma) 
was used as a blocking agent in the tubing containing the assay solution. 
 
2.4. Microfluidic devices 
2.4.1. Detailed description of microfluidic devices 
Device #1 is a simple coflow droplet maker which created droplets containing yeast cells (Figure 
2.2).  The channels in this device were 25µm tall.  The droplets formed by this device were 
75µm in diameter.  There were three inputs into Device #1: cells, medium, and a fluorinated 
oil/surfactant mixture.  The yeast cells injected into the microfluidic Device #1 originated from a 
shake flask culture at an OD600 ~ 0.2 so that all of the cells were in the exponential growth 
phase.  The cells were then centrifugated at 500×g for 15 minutes, resuspended in PBS, and this 
process was repeated three times to remove all remnants of the supernatant.  The reinjected cell 
solution contained 0.025% (w/v) xantham gum to prevent cells from settling in the input syringe. 
 
CHAPTER 2: High Throughput Screening Platform 
  46  
The medium was at a 2× concentration since it would be diluted in the device.  The distribution 
of cells in a droplet follows a Poisson distribution: 
( ; )
!
λλλ
−
=Prob
kek
k  Equation 2.1 
where λ is the average number of cells per droplet and the equation calculates the probability of 
finding a droplet with k cells.  Figure 2.3 shows a sample distribution of cells in droplets based 
on two cell concentrations.  At a cell density of 0.15 (λ = 0.54), 30% of the droplets have 1 cell, 
10% have 2 cells, and 60% are empty.  For an OD600 = 0.05 (λ = 0.19), 16% have 1 cell, 1% 
have 2 cells, and 83% are empty.  Thus, the cell density can be varied to ensure that the number 
of droplets with one cell is maximized which allows for higher throughput or that there is a lower 
percentage of droplets with more than one cell which reduces the amount of error in the system. 
 
   
Figure 2.2: (Left) Mask design for droplet making device which contains 3 inputs for the oil, 
cell culture medium, and the cells, and one output.  (Right) Picture of actual microfluidic device 
with 3 droplet makers.  The actual channels are highlighted in blue. 
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Figure 2.3: Poisson distribution of cells in droplets at two different incoming cell densities 
which shows how the number of droplets with single cells or the total number of droplets with 
less than two cells can be optimized 
 
In order to place approximately one cell in every two to three droplets, the OD600 cell 
density of the incoming yeast cells was approximately 0.1 although the exact value can vary 
from strain to strain (Table 9.1 and Figure 2.4).  This fraction of droplets with cells was chosen 
to reduce the number of droplets with more than one cell and thus minimize the number of false 
positives.  The number of droplets with single cells is high enough to ensure sufficient 
throughput.  The droplets formed in the droplet maker were collected in a syringe and cultured 
microaerobically by capping the syringe (Figure 2.5). 
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Figure 2.4: Single cells in droplets 
immediately after collection 
 
Figure 2.5: TAL1 cells in droplets after 
culturing for 3.5 days 
 
After culturing the cells for a predetermined amount of time, the droplets from the 
syringe were reinjected into Device #2 which also contained modules for assay droplet 
formation, droplet coalescence, fluorescence detection, and sorting (Figure 2.6).  The channels in 
this device were 75µm tall.  Two of the inputs into this device were for droplet reinjection and 
additional oil to space the droplets properly.  The other two inputs were for assay droplet 
production. The reinjected and assay droplets flowed in an alternating sequence through the 
channel leading up to the coalescence module.  The assay droplets had a diameter of 225µm 
which was larger than the 75µm diameter for the reinjected droplets.  Due to the parabolic 
velocity profile in the channels, the reinjected droplets flowed faster than the assay droplets so 
that the droplet pairs were in contact before reaching the coalescence electrodes.  The electrodes 
applied an AC potential of 1kV at a frequency of 20kHz to destabilize the droplet interface 
which caused the droplets to combine (Figure 2.7) (Ahn, Agresti et al., 2006).  When using this 
device, it was more preferable to have an excess of assay droplets because uncoalesced assay 
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droplets only slightly reduced the throughput while having excess reinjected droplets produced 
measurement errors due to two reinjected droplets coalescing with an assay droplet. 
 
Figure 2.6: (Left) Mask design for second device where reinjected droplets and assay droplets 
are coalesced which initiates the assay reaction, the delay lines allow the assay reaction to 
proceed, and the droplets are sorted based on the fluorescence intensity.  Desired droplets flow 
into the upper sorting channel and undesired droplets flow into the lower channel.  (Right) 
Actual second device where the channels are highlighted in blue.  The wires are connected to the 
electrodes on the device. 
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Figure 2.7: Coalescence of droplets: (Left) Large (assay) and small (reinjected) droplets are in 
contact. (Middle) AC field from electrodes causes droplet interfaces to disappear which initates 
coalescence. (Right) Droplet coalescence is complete. 
 
After coalescence, the droplets flowed through long microfluidic channel delay lines to 
allow the assay reaction to proceed.  After traveling through the channels for 30 seconds, a blue 
laser spot at a wavelength of 488nm was placed in the middle of the channel to excite the 
fluorescent dye, resorufin.  This dye emitted light at an orange wavelength and was detected by a 
photomultiplier tube with a filter centered at 593nm (Figure 2.8).  A software program written 
with LabView was used to analyze the detection data and record the maximum resorufin 
fluorescence intensity for each droplet. 
 
Figure 2.8: Detection system where blue laser shines on device which excites 
resorufin dye.  Emitted light is detected with photomultiplier tube. 
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A FEMLab simulation of the electrical potential gradient produced by the sorting 
electrodes was performed to determine the appropriate design for a functional microfluidic sorter 
device.  Previous sorting designs used much thinner and narrower channels (e.g., 25μm high and 
50μm wide.  The channel height is defined by the thickness of the photoresist used to pattern the 
PDMS channel mold.  Using 25μm thick resist allowed for the spacing between the electrodes 
and the channel to be 25μm.  Because of the long serpentine channels needed in this 
coalescence/sorter design, the channel height was 75μm and the width was 150μm.  However, a 
25μm spacing could not be achieved by using 75μm thick resist.  Before performing the 
FEMLab calculation, it was assumed that a small spacing was necessary for the sorter to 
function.  The sorter works through the property of dielectrophoresis where the droplet is pulled 
towards the electrode if there is a sufficiently high electrical potential gradient in the channel.  In 
the FEMLab simulation, the live electrode has a 1kV potential and the other is at ground.  As can 
be seen in Figure 2.9, the desired large potential gradient in the channel exists, and this design 
was used to produce a functional droplet sorting device. 
The sorting portion of the device had two outlet channels.  The upper channel, which 
contained the “desired” droplets, had a constriction to produce a higher hydrodynamic resistance.  
As a result, the droplets naturally flowed into the lower “undesired” channel.  Droplets only 
flowed into the “desired” droplet channel when the detection system measured a fluorescence 
within a predetermined range.  At that time, a 2kV AC pulse at 900Hz was applied to the 
electrodes.  The resulting AC field created an electrical potential gradient across the channel 
which dielectrophoretically moved the droplet towards the electrodes and into the “desired” 
droplet channel (Figure 2.10) (Ahn, Kerbage et al., 2006).  The contents of the two channels 
were collected using 1mL unfiltered pipet tips.  The resulting emulsion was separated into two 
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distinct phases using a fluorinated alcohol, and the aqueous phase, which contained the cells, was 
added to a liquid or solid culture to grow the cells.  If the droplets flowing through the channels 
had insufficient spacing, the “undesired” droplets flowed into the “desired” channel.  Optimizing 
the flow rates of the reinjected and assay droplets allowed for the control of the spacing between 
droplets, but the pairs of droplets needed a longer time to come in contact with each other in the 
coalescence module.  As a result, there was a long channel before the coalescence electrodes in 
this design (Figure 2.6).  This sorting system was designed to ensure that all “desired” droplets 
were pulled into the “desired” channel.  Thus, there were negligible false negatives.  The 
percentage of false positives, which was due to random droplets flowing into the “desired” 
channel, was 2.5% (Table 9.2). 
 
Figure 2.9: FEMLab calculation of electrical potential by sorter electrodes.  Picture contains 
sorter electrodes and PDMS channels near sorter.  Red color means higher electrical potential 
and blue is lower electrical potential.  Potential gradient can be seen at sorter electrode when 
looking at vertical cross-section through device. 
Electrode 
at 1kV
Ground 
Electrode
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Figure 2.10: Sorting of Droplets.  Droplet flows through blue laser spot (white dot).  Based on 
fluorescence measurement, droplet is pulled by sorting electrodes and flows into top channel.  
Second droplet is not pulled and flows into lower channel. 
 
2.5. Assay reaction in droplets 
2.5.1. Assay Reaction 
The high throughput screening system is flexible because any fluorescent assay system can 
be used to measure the concentration of the metabolite of interest.  The assay used in this thesis 
was one based on an oxidase enzyme/horseradish peroxidase/Amplex UltraRed system and 
allowed for the use of any of the various oxidase enzymes which exist in nature (Table 2.1).  The 
generic assay reaction is shown below: 
2 2 2
Horseradish Peroxidase
1
2 2 2 22
(Not Fluores
Metab
(Flu
olite Oxidase
orescent)cent)
 + O Oxidized Metabolite + H O
H O  + Amplex Ul RetraRed sorufiH O + 
Target Metabo
O
lite
+ n  
→
→
 
In this reaction, the amount of fluorescent resorufin produced is proportional to the concentration 
of the metabolite of interest in solution.  In the droplet system, the assay reaction is initiated once 
the droplet coalescence.  The reaction time in a droplet was 30 seconds at room temperature. 
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Metabolite Oxidase Enzyme 
Xylose Pyranose oxidase 
Glucose Glucose oxidase 
L-aspartic acid L-aspartate oxidase 
Succinic acid Succinate dehydrogenase 
Lactic acid Lactase oxidase 
Table 2.1: Examples of detectable metabolites and their corresponding oxidase enzymes 
 
2.5.2. Assay compatibility with microfluidic emulsion system 
Much work was performed to ensure that the microfluidic emulsion system was 
compatible with the enzymatic assay.  Most of this initial work was performed with Amplex Red 
instead of Amplex UltraRed.  Fluorescent microscopy images were initially used to determine if 
the assay reaction performed as expected.  However, as can be seen in Figure 2.11 and Figure 
2.12, even 30 seconds of exposure to the green light used to excite resorufin caused the Amplex 
Red to photooxidize and become fluorescent.  As a result, the performance of the assay was only 
tested using the droplet detection system since the droplets are exposed to the laser for less than a 
second. 
One of the major initial issues with the assay was that a high background signal was 
detected in the droplets.  Furthermore, droplets containing only horseradish peroxidase (HRP) 
and Amplex Red fluoresced.  The continuous phase of the emulsion is the FC-40 fluorinated oil 
and a fluorosurfactant containing a poly(ethyleneglycol) (PEG) hydrophilic group on one end 
and and a perfluoro-block on the other.  PEG groups on surfactants can contain peroxide groups 
because of factors such as the presence of oxygen (Kumar & Kalonia, 2006).  Since the original 
surfactants were synthesized in the presence of oxygen, it probably contained peroxide groups 
which react with HRP and Amplex Red to produce fluorescent resorufin.  If the cE2K0420 and 
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cE2K0665/EA surfactants from Raindance Technologies which were synthesized in the presence 
of pure nitrogen were used instead, the background signal in the droplets was extremely low. 
 
 
Figure 2.11: Fluorescent microscope image 
of Amplex Red only in solution immediately 
after the green excitation light was turned 
on.  Low fluorescence is observed 
 
Figure 2.12: Same sample as in Figure 2.12 
except that it was exposed to the green 
excitation light for 30 sec.  Much higher 
fluorescence is observed. 
 
It was also observed that an assay reaction in a 96 well plate did not match that in a 
droplet.  When performing an assay reaction in droplets with Amplex Red, HRP, and hydrogen 
peroxide, it had significantly less fluorescence compared with a 96 well plate experiment.  
However, once the emulsion was broken, the assay performed as expected.  Thus, it was 
hypothesized that the inhibition to the reaction must be occurring on the droplet interface.  
Proteins are known to adhere to the droplet interface when an incompatible surfactant is used.  
However, no localization of HRP enzyme was observed when biotinylated HRP with 
fluorescein-tagged avidin was used to visualize the enzyme.  Furthermore, neither adding BSA to 
the assay to prevent enzymes from adhering to the interface nor increasing the HRP 
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concentration had any effect on the assay.  Thus, the source of the assay inhibition could not be 
determined.  However, it was observed that using a 5× higher hydrogen peroxide or 25× higher 
oxidase enzyme concentrations in the droplet reaction produced a fluorescent intensities similar 
to that for a 1× concentrations in a 96 well plate. 
Yeast culture medium becomes increasingly acidic as the fermentation progresses and 
this pH change can affect the fluorescence.  Initially, Amplex Red was used but was later 
changed to Amplex UltraRed due to its lower pH sensitivity (Figure 2.13) (Invitrogen, 2009). 
 
Figure 2.13: pH Sensitivity of Amplex UltraRed and Amplex Red fluorescence 
Furthermore, some assay reactions, such as the one for xylose detection using pyranose oxidase, 
are more sensitive at lower substrate concentrations when AmplexUltra Red is used.  It was also 
observed that the assay enzymes adhered to the tubing which connected the syringe to the 
microfluidic device.  This issue was solved by pre-treating the tubing with 1% BSA solution for 
5 minutes before use. 
 
The initial microfluidic delay line designs used channel dimensions of 25µm × 100µm (H 
× W).  However, this design caused leakage in the channels and made it difficult to apply 
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Aquapel because there was a back pressure in the channels.  It also caused reinjection and 
droplet formation issues.  The following equation can be used to estimate the back pressure in a 
channel assuming plane Poiseuille flow assuming that the channel width is much larger than the 
height. 
3
12 μ⎛ ⎞Δ = − ⎜ ⎟⎝ ⎠
QP L
h w  Equation 2.2
 
where L is the length of the channel, Q is the volumetric flow rate, μ is the viscosity, h is the 
channel height, and w is the channel width.  Thus, when the channel cross-sectional area (e.g., 
the height and width) increases, the back pressure decreases.  The pressure also decreases with a 
larger cross-sectional area for a constant volumetric flow rate.  This causes a reduction in the 
linear flow rate and the channel length which would be needed for a specific droplet travel time.  
The back pressure changes more significantly when the channel height is changed compared 
with the width.  Table 2.2 shows how the back pressure varies based on the channel dimensions 
when the volumetric flow rate is 500μL/hr and the delay time is 30 seconds.  After performing 
these calculations, delay line channel dimensions and the final dimensions of the second 
microfluidic device for coalescence and sorting were adjusted to a 75μm height and 150μm 
width. 
Channel Dimensions  
(Height × Width in μm) 
Back Pressure (atm) with Poiseuille Flow 
25 × 100 59.7 
75 × 150 0.24 
100 × 300 0.03 
Table 2.2: Back pressure variation with channel dimensions 
 
CHAPTER 2: High Throughput Screening Platform 
  58  
2.5.3. Xylose Assay Reaction in Droplets 
To test the xylose assay reaction in droplets through the delay lines, the microfluidic 
device shown in Figure 2.14 was used.  The channels in this device were 75µm tall.  This device 
mixes two aqueous inputs.  One contains a specific amount of xylose and the other has the assay.  
The aqueous stream is mixed and droplets are formed when it contacts the oil stream.  Then, the 
droplets flow through long microfluidic channel delay lines to allow the assay reaction to 
proceed.  This device was designed so that fluorescence could be measured at different locations 
along the delay line to determine the optimal reaction time.  Several experiments were run using 
this device in which the xylose concentration was varied. 
 
Figure 2.14: Microfluidic device to create calibration curves.  It contains one oil input and two 
aqueous inputs.  Fluorescence can be measured anywhere along the delay lines. 
 
Figure 2.15 and Figure 2.16 show that the fluorescence increases with increasing xylose 
concentration and the resulting fluorescence distributions have low variations.  2U/mL of 
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pyranose oxidase can be used when the maximum xylose concentration is 5g/L while 0.1U/mL 
would be used for concentrations up to 20g/L. 
 
Figure 2.15: Fluorescence of xylose samples when using 2U/mL pyranose oxidase in 
the assay mixture.  (Left) Fluorescence distributions for four concentrations (0, 1, 2.5, 
and 5g/L) of xylose (concentrations reported are the values when injected into 
device).  (Right) Calibration curve using the four xylose concentrations. 
 
 
Figure 2.16: Fluorescence of xylose samples when using 0.1U/mL pyranose oxidase 
in the assay mixture.  (Left) Fluorescence distributions for five concentrations (0, 2.5, 
5, 10, 20g/L) of xylose (concentrations reported are the values when injected into 
device).  (Right) Calibration curve using the five xylose concentrations. 
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2.5.4. Glucose Assay Reaction in Droplets 
To confirm that the glucose assay reaction functioned properly in the droplets, a 
calibration curve for 0-5g/L glucose was generated in a similar fashion to the ones for xylose.  
2U/mL of glucose oxidase was utilized in the assay reagent mix.  The resulting calibration curve 
shown in Figure 2.17 also has a well-correlated glucose concentration to fluorescence trend. 
 
Figure 2.17: Glucose calibration curve using 2U/mL glucose oxidase 
 
2.5.5. No leakage of glucose in droplets 
Initially, ethanol production in droplets was the initial application of this screening 
system (Chapter 6).  However, it was discovered that ethanol leaks out of the droplets due to the 
solubility of ethanol in the fluorinated oil.  To determine if other chemicals did not have this 
same leakage problem, two populations of droplets were “incubated” in a syringe for six hours to 
simulate actual cell culturing conditions.  One population had 1g/L glucose and the other 
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contained 5g/L.  After incubation, the droplets were reinjected into a coalescence/detection 
device (Figure 2.18). 
 
Figure 2.18: Devices to test droplet leakage.  The first device produces droplets containing 
glucose.  After incubating the droplets for 6 hours, the second device combines these droplets 
with droplets containing a glucose assay and detects the resulting fluorescence. 
 
Figure 2.19: Fluorescence distributions of 1g/L (blue) and 5g/L (red) glucose droplets which 
were collected separately.  The green distribution is the fluorescence for a mixture of the two 
droplet populations incubated for 6 hours before reinjection into the second device. 
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The resulting fluorescence distributions are reported in Figure 2.19 along with the distributions 
for the initial populations.  The fluorescence distribution for the mixed population has two 
defined distributions which match the distributions for the individual 1g/L and 5g/L populations.  
Thus, it was concluded that glucose does not leak out of the droplets. 
 
 
2.5.6. Assay cost advantages 
1mL of 2.6mg/mL Amplex UltraRed, 100U/mL pyranose oxidase, and 10U/mL HRP 
costs $4.16.  Performing one round of screening to sort 104 clones using 96 well plates costs 
$2078 because 104 wells with 50µL of assay solution is 500mL.  On the other hand, using 
droplets costs $4.16.  In this case, even though 2×104 droplets with 3nL of assay solution have a 
total volume of 60µL, the volume used to calculate the cost is 1mL, which is the practical 
volume used to fill a 1mL syringe.  These calculations show that there is a significant assay 
chemical price advantage when using the droplet technology. 
 
2.6. Conclusions 
A high throughput screening system was developed using microfluidic droplet emulsion 
technology.  This is the first fully integrated system which can culture, assay, and sort cells based 
on the extracellular metabolite concentration.  The demonstrated system can screen for 104 
clones in 2-3 hours.  Additional optimization of the microfluidic device design would allow for 
even higher throughput screening where libraries of 105 in size can be sorted.  This system has 
the ability to measure multiple types of metabolites simply by through the simple substitution of 
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the appropriate oxidase enzyme in the assay mix.  Furthermore, any fluorescent assay or 
reporting system could be incorporated to quantify the phenotype.  The measurement of xylose 
and glucose concentrations were described, but the assay could also be used to measure other 
sugars, amino acids, and organic acids.  Since the droplet volumes are in the nanoliter range, 
small changes in the metabolite levels can be detected even when starting with a single cell in a 
droplet.  These single cells can be cultured for days or weeks to amplify the metabolite 
production or secretion levels.  Also, the ability to add assay reagents after cell culturing allows 
the cells to grow in the same medium to which they would be exposed in a shake flask culture.  It 
also allows for microaerobic culturing and the measurement of metabolite consumption.  To 
estimate how quickly oxygen is depleted in a droplet, the following calculation can performed 
assuming that the specific oxygen uptake rate is 5 mmol O2/(g Cell × hr) (Larsson, Vonstockar, 
Marison, & Gustafsson, 1993).  The solubility of oxygen in water at 25ºC is 0.3mmol/L.  A 
0.3nL droplet contains is 9×10-11 mmol of oxygen.  One cell is 7.9pg so all of the oxygen is 
consumed in 12 minutes.  Since individual cells are encapsulated in an individual droplet, the 
biological diversity of either a clonal population or a library can also be characterized through 
the use of only the fluorescence detection system.  There is also an economic advantage in terms 
of using small amounts of assay chemicals.  This platform provides the biotechnology 
community with a powerful tool to screen libraries which were previously difficult or impossible 
to screen. 
 
 
CHAPTER 3: Screening for High Xylose Consuming Yeast Strains 
  64  
 
 
 
 
Chapter 3. SCREENING FOR HIGH XYLOSE CONSUMING YEAST 
STRAINS 
 
 
 
 
3.1. Introduction 
3.1.1. Motivation 
The high throughput screening system was utilized to identify high xylose consuming 
strains of Saccharomyces cerevisiae.  The consumption of xylose was chosen as the initial 
demonstration of this platform because of its relevance to biofuels research.  As shown in Figure 
3.1, the Energy Independence and Security Act of 2007 (EISA) mandates that the cellulosic 
biofuel production must be 16 billion gallons by 2022 (H.R.6, 2007).  Thus, the United States 
needs to develop commercially-viable biofuel production technologies which use lignocellulosic 
feedstocks.  These feedstocks, such as corn stover, contain a significant amount of xylose as a 
product of hemicelluloses hydrolysis (Chundawat, Venkatesh, & Dale, 2007).  However, S. 
cerevisiae, which readily converts glucose to ethanol, cannot naturally ferment xylose (Kuyper et 
al., 2005).  As a result, engineering a S. cerevisiae strain to readily utilize xylose is a critical step 
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in developing a viable lignocellulosic ethanol process.  Having a high throughput screening 
method for xylose can aid identifying these strains. 
 
Figure 3.1: Cellulosic biofuel volume as mandated by the Energy 
Independence and Security Act of 2007 
 
3.1.2. Overview 
This chapter will focus on the ability to select for high xylose consuming strains.  Once 
the system was proven to have the capability to enrich for high xylose consuming strains even 
when these strains were at a very low percentage of the initial population, several libraries were 
screened.  The first library was constructed by shuffling the genes of two putative transporters 
from non-S. cerevisiae yeast species.  Since S. cerevisiae transporters xylose through hexose 
transporters, instead of through the specific xylose transporters which exist in other yeast 
species, it has been suggested that xylose transporter in S. cerevisiae may limit the xylose 
utilization (Gardonyi, Jeppsson, Liden, Gorwa-Grausland, & Hahn-Hagerdal, 2003).  Thus, it is 
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important to identify the xylose-specific transporters from these other species through their 
homology to a transporter which has xylose transporter activity such as the S. cerevisiae HXT7 
transporter.  Furthermore, the shuffling of these xylose transporter genes may allow for the 
discovery of higher affinity transporters.  A second library contained the simple overexpression 
of genes which can affect the xylose utilization.  These genes included the putative xylose 
transporter genes mentioned previously, genes to rebalance cofactors, native fermentation 
pathway genes, and P. stipitis pentose phosphate pathway genes.  Rebalancing cofactors is 
important when a strain contains the XYL1 and XYL2 genes which encode for enzymes which 
utilize additional NAD(P)H and NAD+ cofactors, and improving the expression of downstream 
pathway genes allows the metabolic pathway to utilize the metabolites produced by the direct 
utilization of xylose.  The last library which will be described was used to identify mutations 
produced during the evolution of the H131E-A31 strain.  Since this mutations can be anywhere 
in the genome, a genomic DNA library of this strain was incorporated into H131-A31, which is 
the unevolved version of that strain.  By selecting for high xylose consuming mutants from that 
library, mutated genes which allow for high xylose consumption can be identified. 
 
3.1.3. Description of xylose consuming yeast strains 
The two main strains utilized in the experiments described in this chapter are H131 and 
H131-A31.  In both of these strains, the native pentose phosphate pathway genes RKI1 (ribose-5-
phosphate ketol-isomerase), RPE1 (ribulose 5-phosphate epimerase), and TKL1 (transketolase) 
were overexpressed along with the P. stipitis TAL1 (transaldolase) and XYL3 (D-xylulokinase) 
genes.  The expression of these genes ensures that the additional flux from the utilization of 
xylose is diverted towards the glycolytic pathway.  The differences between the two strains are 
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the genes which code for the enzymes catalyzing the reaction from D-xylose to D-xyulose.  In 
H131, a two-step reaction of the P. stipitis XYL1 (D-xylose reductase) and XYL2 (xylitol 
dehydrogenase) is utilized while H131-A31 uses the Piromyces sp. E2 XYLA (xylose isomerase) 
(Figure 3.2) (Jeffries, 2006).  The XYL1 and XYL2 genes create a cofactor imbalance caused by 
the utilization of NAD(P)H and NAD+ while XYLA does not.  The other strain described in this 
chapter is TAL1 which is similar to H131 but contains only the XYL1, XYL2, XYL3, and TAL1 
genes. 
 
Figure 3.2: Xylose utilization pathway engineering for S. cerevisiae strains (Jeffries, 2006) 
 
CHAPTER 3: Screening for High Xylose Consuming Yeast Strains 
  68  
3.2. Materials and Methods 
3.2.1. Yeast strains 
H131 was derived from F1702 (a BF-264-15Daub derivative) and has the genotype 
MAT_a, leu2, ura3, arg4, ade1::ADE1-GPD-PsTAL1, trp1::TRP1-GPDP-ScRKI1-ScRPE1, 
his2::HIS2-GPDP-ScTKL1 with pRS426-GPDP-XYL1-CYCT-GPDP-XYL2-CYCT-GPDP-XYL3-
CYCT.  ScRKI1, ScRPE1, and ScTKL1 are the native RKI1, RPE1, and TKL1 genes from S. 
cerevisiae.  XYL1, XYL2, XYL3, and TAL1 genes are from Pichia stipitis.  H131-A31 is similar to 
H131 except its genotype is MAT_a, leu2, ura3, arg4, ade1::ADE1-GPD-PsTAL1, trp1::TRP1-
GPDP-ScRKI1-ScRPE1, his2::HIS2-GPDP-ScTKL1 with pRS426-GPDP-XYLA-CYCT-GPDP-
XYL3-CYCT.  XYLA is the xylose isomerase gene from Piromyces sp. E2.  H131E-A31 is the 
evolved version of H131-A31.  TAL1 was created from YSX3 which had a genotype of MAT_α, 
trp1, leu2::LEU2-GAPDHP-XYL1 ura3::URA3-GAPDHP-XYL2 Ty3::NEO-XYL3.  TAL1 is 
YSX3 with the pRS424TEF-PsTAL1 plasmid. 
Three libraries were evaluated for improved xylose consuming mutants.  These libraries 
were a xylose transporter library, a small library which contained various genes which may 
improve xylose consumption (which will also be referred to as the “xylose consumption 
library”), and a genomic DNA library and were constructed as follows.  The xylose transporter 
library consisted of an H131 background with a library on a pRS425GPD plasmid which 
contained the shuffling of two putative transporter genes from Debaryomyces hansenii (gene 
XM_458532) and Candida glabrata strain CBS138 (gene XM_444845).  The control for the 
library contained the original pRS425GPD plasmid.  The xylose consumption library consisted 
of an H131 background with the genes and vector combinations listed in Table 3.1.  The control 
for the library had the same background and a plasmid without an insertion. 
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Table 3.1: Strains in xylose consumption library contained with genes which may improve 
xylose consumption (e.g., putative xylose transporter genes, genes to rebalance cofactors, native 
fermentation pathway genes, P. stipitis pentose phosphate pathway genes).  All genes are on a 
pRS415GPD (single copy) plasmid and most are also on a pRS425GPD (multicopy) plasmid 
 
The genomic DNA library construction is illustrated in Figure 3.3.  The library 
background was the H131-A31 strain.  The library was constructed by performing a genomic 
DNA prep of H131E-A31 using the Wizard Genomic DNA purification kit (Promega) and 
partially digesting the DNA with Sau3AI (New England Biolabs).  Fragments larger than 3kb 
were selected on an agarose gel, and the DNA was purified with a gel extraction kit and purified 
again with ethanol precipitation.  pRS415 was used as the backbone and was digested with SalI.  
Both the insertion fragments and the backbone were incubated with the Klenow fragment of 
DNA polymerase I and the appropriate dNTPs to reduce the overhang length from 4 to 2 
basepairs to decrease the frequency of self-ligation (Rose & Broach, 1991).  The backbone was 
Organism Gene Genbank Accession Number pRS415GPD (Low Copy) pRS425GPD (High Copy)
Candida albicans SC5314 RGT2 XM_715292 Y Y
Candida albicans SC5314 HGT3 XM_710040 Y Y
Candida albicans SC5314 HXT62 XM_714504 Y Y
Candida glabrata CBS138 CAGL0A01826g XM_444845 Y Y
Debaryomyces hansenii CBS767 DEHA0D02167g XM_458532 Y Y
Debaryomyces hansenii CBS767 DEHA0B16665g XM_457669 Y Y
Debaryomyces hansenii CBS767 DEHA0D20383g XM_459306 Y Y
Pichia stipitis SUT1 XM_001387861 Y Y
Pichia stipitis SUT2 AF072808 Y Y
Pichia stipitis XUT3 XM_001387101 Y Y
Pichia stipitis XUT4 XM_001386678 Y Y
Pichia stipitis XUT5 XM_001385925 Y Y
Pichia stipitis XUT6 XM_001386552 Y Y
Saccharomyces cerevisiae HXT5 X77961 Y Y
Saccharomyces cerevisiae HXT7 Z31692 Y Y
Trichoderma reesei XLT1 AY818402 Y Y
Streptococcus mutans GAPN L38521 Y N
Saccharomyces cerevisiae PDC1 X77316 Y N
Saccharomyces cerevisiae ADH1 Z74828 Y N
Pichia stipitis RPE1 XM_001386542 Y N
Pichia stipitis RKI1 XM_001382962 Y N
Pichia stipitis TKT1 XM_001382648 Y N
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also dephosphorylated to prevent self-ligation.  After ligating the fragments and the backbone 
together with T4 ligase, the resulting plasmid was transformed into ElectroMAXTM DH5α-E 
(Invitrogen) and plated on ampicillin-resistant agar petri dishes.  This DH5α library contained 
106 colonies.  The plasmid was miniprepped and transformed into the H131-A31 strain using the 
Frozen-EZ Yeast Transformation IITM kit (Zymo Research).  The resulting yeast library 
contained 5×105 colonies.  The control for the library had the same background and a plasmid 
without an insertion. 
 
 
Figure 3.3: This schematic of the genomic DNA library construction shows that digested 
fragments of DNA from H131E-A31 (evolved strain) were inserted into a plasmid.  This plasmid 
was transformed into H131-A31 (unevolved strain). 
 
3.2.2. Shake flask fermentations 
The yeast fermentations used in this study were performed in 250mL Erlenmeyer flasks 
at 30ºC using an orbital shaker rotation speed of 225rpm.  Microaerobic fermentations were 
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performed by bubbling nitrogen through the shake flask contents and sealing with a rubber 
stopper with a needle.  The culturing medium contained 6.7g/L yeast nitrogen base without 
amino acids (Difco), complete synthetic medium (MP Biomedicals) with the appropriate amino 
acid dropouts to maintain the plasmids, and the desired concentration of xylose.  In the 
experiments using H131-A31 and related strains, the medium contained 20g/L xylose.  For all 
other experiments, the xylose concentration was 5g/L. 
 
3.2.3. Droplet fermentations 
The culture medium in the droplets contained 1× yeast nitrogen base without amino acids 
(Difco), complete synthetic medium (MP Biomedicals) with the appropriate amino acid dropouts 
to maintain the plasmids, and 5g/L xylose.  Microaerobic culturing of droplets occurred at 30ºC 
in a capped 1mL syringe. 
 
3.2.4. Analytical measurements 
The microfluidic droplet screening system described in Chapter 2 was used to culture 
yeast cells in droplets, measure the remaining amount of xylose using the Amplex 
UltraRed/pyranose oxidase enzyme system, and select for high xylose consuming strains. 
For the quantification of xylose concentrations from shake flasks, cell-free culture 
supernatants were filtered through 0.2-µm-pore-size polytetrafluoroethylene membrane syringe 
filters (VWR International).  These samples were analyzed in a high-performance liquid 
chromatography (HPLC) system with a Waters 2690 Separations module connected with a 
Waters 410 refractive index detector (Waters).  The samples were separated on a BioRad 
Aminex HPX-87H ion exclusion column for organic acid analysis with 14mM sulfuric acid as 
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the mobile phase at a flow rate of 0.7mL/min.  For cell density determinations, the optical 
densities of cultures were measured at 600 nm using an Ultrospec 2100 pro UV/visible 
spectrophotometer (Amersham Biosciences). 
 
3.3. Results 
3.3.1. Xylose measurements of droplets containing xylose consuming cells 
The fluorescence distribution of the H131 strain cultured in droplets for 2 days using biological 
replicates has a bimodal shape (Figure 3.4).  In this graph, the low fluorescence mode represents 
a low xylose concentration, therefore these are droplets with cells a high xylose consumption.  
One the other hand, the high fluorescence mode represents empty droplet which have the high 
initial xylose concentration and a low xylose consumption.  The high fluorescence population 
contains mainly empty droplets while the lower fluorescence distribution contains droplets with 
cells.  The fluorescence distribution in Figure 3.4 can be converted to an estimated xylose 
concentration distribution by using the xylose fluorescence vs. xylose concentration data from 
Figure 2.15 (Figure 3.5).  The low xylose concentration distribution contains the cells and the 
average xylose concentration of these droplets was estimated as 2.5g/L.  Comparing this to the 
2.7g/L HPLC measurement of a 25mL culture demonstrates that the xylose concentration 
measured in droplets containing cultured yeast cells approximates that in a bulk culture (Figure 
3.6).  The next step was to enrich a high xylose consuming strain from a mixed population. 
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Figure 3.4: Fluorescence distribution data from the H131 strain after a 2 day culture.  The 
bimodal distribution contains droplets with cells on the left and empty droplets on the right. 
 
Figure 3.5: Estimated xylose concentration distribution in droplets.  This graph was 
generated by combining the fluorescence distribution data in Figure 3.4 and the xylose 
calibration data from Figure 2.15. 
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Figure 3.6: Xylose concentration time course of H131 from a 
25mL microaerobic culture over the period 3 days. 
 
3.3.2. Comparison of H131 and TAL1 fluorescence data 
First, it must be established that the fluorescence distributions of droplets encapsulating 
yeast cells with varying xylose-assimilation capabilities were sufficiently different to allow such 
droplets to be efficiently sorted.  To this end, two strains of S. cerevisiae were selected, H131 
and TAL1, where H131 is the higher xylose consuming strain (Figure 3.7).  Fluorescence 
distribution data were measured at various time points using biological replicates. Representative 
distributions from the H131 and TAL1 strains after 2 days of culturing are shown in Figure 3.8. 
The bimodal distribution is rather typical, with the higher fluorescence population representing 
droplets that contained no cells and therefore had a xylose concentration equal to the initial 
xylose concentration of 5g/L. Cell-containing droplets exhibit lower fluorescence. 
CHAPTER 3: Screening for High Xylose Consuming Yeast Strains 
  75  
 
Figure 3.7: HPLC measurements of H131 and TAL1 xylose consumption 
from 25mL micraerobic fermentation over the period of 3 days which 
shows that H131 consumes xylose at a higher rate than TAL1 
 
Figure 3.8: Fluorescence distributions of two populations of droplets: one containing high 
(H131) and one of low (TAL1) xylose-consuming yeast strains, after 2 days of culturing.  A 
larger fraction of droplets with low xylose concentration is observed for strain H131. 
CHAPTER 3: Screening for High Xylose Consuming Yeast Strains 
  76  
 
When comparing the fluorescence distributions for the H131 and TAL1 strains, it can be seen 
that there were more droplets with low fluorescence for the H131 strain compared with those for 
TAL1. This suggests that the xylose concentration in the H131-containing droplets is lower, as 
expected for these xylose-consuming cells. 
Using the fluorescence distribution data from Figure 3.8, the fraction of total droplets 
with fluorescence below a certain threshold can be determined to allow for more quantitative 
comparisons.  Results for the 2-day culturing experiment show a statistically significant 
difference between the fractions of droplets containing the two types of strains in the 
fluorescence ranges of 0-0.5, 0-0.6, and 0-0.7 (Figure 3.9). 
 
Figure 3.9: Effect of fluorescence range on the fraction of H131- and TAL1-
containing droplets after 2 days of culturing. (* - p < 0.05) 
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The ratio of H131- to TAL1-containing droplets in these ranges was also calculated and found to 
be as high as 25 (Figure 3.9).  This ratio is an estimate of the enrichment in H131 cells that 
would be obtained in the outgoing population if droplets were perfectly sorted based on these 
ranges and the incoming population contained equal cell concentrations of the two strains. A 
range of 0-0.6 fluorescence was selected on the basis of these results.  Analysis of similar data 
obtained at different time points shows that the percentage of droplets in the 0-0.6 fluorescence 
range increased in both strains with time, but the enrichment decreases after 2 days, presumably 
due an already high depletion of xylose in the H131-containing droplets (Figure 3.10). 
 
 
Figure 3.10: Effect of culturing time on the fraction of H131- and TAL1-containing droplets 
using data from the 0-0.6 fluorescence range (* - p < 0.05). Blue and red bars are the percentage 
of droplets of each strain in a fluorescence bin range. Black triangles are the ratio of H131 to 
TAL1 droplet percentages in a range. 
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3.3.3. Enrichment of H131 from equal H131 to TAL1 mixture 
A test was performed to determine whether the microfluidic assaying-sorting device was 
capable of enriching the H131 cell population by screening an incoming cell population 
comprising equal proportions of the H131 and TAL1 strains.  This mixture was cultured on 
xylose for two days, and the resulting cell-containing droplets were screened for low xylose 
content using the microfluidic device.  The difference in the auxotrophic markers for the two 
strains was used to determine the contents of the sorted droplets.  The H131 strain does not have 
the ability to grow on leucine deficient medium while TAL1 does.  As a result, the sorted 
population was grown on two types of agar plates, one that contained leucine on which both 
strains could grow and another which did not contain leucine and only permitted growth of 
TAL1 (Figure 3.11).  After culturing the plates, the number of colonies on each type of plate was 
counted.  The TAL1 colony forming units (CFU) was equal to the number of colonies on the 
leucine deficient plates while the H131 CFU was calculated by subtracting the number of TAL1 
colonies from the total number of colonies on the leucine plates.  The fluorescence data from two 
screening experiments (carried out with sorting gates of 0-0.6 and 0-0.7) are shown in Figure 
3.12.  For the two fluorescence gates used for droplet sorting (0-0.6 and 0-0.7), H131 
enrichments of 18× and 22× were obtained, respectively (Figure 3.13).  It is also noted that H131 
enrichment due to the cell growth difference between the two strains was only 2.8×, which is 
significantly lower than the total enrichments observed. 
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Figure 3.11: After performing the enrichment of H131/TAL1 mixtures, the cells in the droplets 
were grown on two types of agar plates: ones with leucine and others without leucine.  The 
different types of agar plates was used to quantify the sorted populations since H131 could not 
grow on leucine deficient medium but TAL1 can. 
 
 
Figure 3.12: Fluorescence distribution of droplets containing a mixture of H131/TAL1 strains. 
The strains were mixed in equal proportions, encapsulated in microdroplets, and their 
fluorescence measured. (dashed line is 0-0.6 range and dotted line is 0-0.7 range). 
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Figure 3.13: Enrichment of H131 yeast strain from 1:1 H131/TAL1 initial mixture. Enrichment 
due to 2 days of growth is 2.8×. Using fluorescence sorting thresholds of less than 0.6 and 0.7 
enriches H131 strain by 18× and 23×, respectively. 
 
3.3.4. Enrichment from “test library” 
Actual cell libraries typically contain a very low number of desired cells in the overall 
cell population.  Hence, two test libraries with incoming desired (H131) to undesired (TAL1) cell 
population ratios of 1:1,000 and 1:10,000 were screened such that droplets having fluorescence 
in the range of 0-0.7 were sorted into the “desired” bin.  A target final population ratio of 1:2.5 
was defined (meaning that if 5 clones were randomly selected, one could be assured of finding 
an H131 cell).  This target was achieved after only one round of screening with the 1:1,000 
library, while two rounds were necessary to screen the 1:10,000 library.  The sequence for one 
round of screening was a preculture of the incoming cells, a shake flask culture which was grown 
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into early exponential phase, droplet encapsulation of cells, and selection of droplets low xylose 
concentrations (Figure 3.14).  The one round of screening enriched the 1:1,000 library by 420× 
and two rounds enriched the 1:10,000 library by 42,600× (Figure 3.15).  These results are in line 
with the enrichment experiments summarized in Figure 3.13.  These results clearly demonstrate 
that our device is capable of isolating cells with high xylose assimilation rates from a population 
comprising cells with varying xylose uptake rates. 
 
 
Figure 3.14: A single round of screening includes the growth of cells in a preculture and a shake 
flask in order to cultivate cells for encapsulation in droplets.  If an additional round of screening 
occurs, part of the sorted population is grown in a preculture to repeat the process.  The 
remaining cells are grown on plates. 
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Figure 3.15: Enrichment of H131 strain from initial 1:1000 and 1:10,000 H131/TAL1 
mixtures. One round of screening yields a 420× enrichment of the H131 strain from an 
initial 1:103 mixture while two rounds of screening enriches H131 by 42,600× from an 
initial 1:104 mixture of H131/TAL1. 
 
3.3.5. Putative xylose transporter gene shuffling library 
Once enrichment of a high xylose consuming strain was demonstrated, a xylose 
transporter library was screened.  This library used H131 as the background and was created 
through the shuffling of two genes, Debaryomyces hansenii XM_458532 and Candida glabrata 
CBS138 XM_444845.  These two genes were identified by BLAST as having the highest amount 
of DNA sequence homology to S. cerevisiae gene HXT7, which has the highest xylose uptake 
affinity for the native S. cerevisiae sugar transporter genes (Altschul, Gish, Miller, Myers, & 
Lipman, 1990; Saloheimo et al., 2007).  The library contained approximately 1000 colonies.  
Two rounds of selection were performed where 5.2% and 2.5% of the droplets were selected 
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from the first and second rounds, respectively.  The sorted cells from the second round were 
grown on agar plates and five of these clones were grown microaerobically in 25mL cultures.  
Mutant 2-3 was identified as the highest xylose consuming strain and was recultured 
microaerobically with biological replicates in 25mL of medium using the entire library and H131 
with a control plasmid as controls.  While both mutant 2-3 and the entire library consumed 
significantly more xylose than the control, the mutant also consumed more than the library as a 
whole during mid-exponential phase (Figure 3.16).  There was a consistent difference between 
the mutant 2-3 and the entire library between 24 and 40 hours (Figure 3.17).  At the 40 hour time 
point, mutant 2-3 had a 4.9% higher xylose consumption, which was also statistically different, 
so the screening platform was able to identify an above average mutant.  The plasmid from this 
library could not be recovered so a retransformation into a clean background was not performed. 
 
Figure 3.16: Xylose consumption comparison of mutant 2-3, the library as a whole, and the 
control strain from gene shuffling library experiments 
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Figure 3.17: Xylose consumption comparison of mutant 2-3 and the library as a whole during 
mid to late exponential phase from gene shuffling library experiment.  At the 40 hour time point, 
mutant 2-3 had a 4.9% higher xylose consumption and the difference was statistically different 
 
3.3.6. Xylose consumption library 
The second library contained 38 strains which could improve xylose consumption.  These 
strains contained a single copy or multicopy plasmid with a single gene.  These genes included 
putative xylose transporter genes, genes to rebalance cofactors, native fermentation pathway 
genes, and P. stipitis pentose phosphate pathway genes.  Two rounds of screening were 
performed on this library where 8% and 4.1% of the droplets were selected from the first and 
second rounds, respectively.  From the population of sorted strains, five mutants were cultured 
microaerobically in shake flasks, and the highest xylose consuming strain, mutant M2, had 7-
31% higher xylose consumption than the control during mid-exponential phase (Figure 3.18). 
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Figure 3.18: Strain M2 xylose consumption of the control and mutant M2 from the xylose 
consumption library.  There is a consistently higher xylose consumption by mutant M2 
 
After sequencing the contents of the plasmid from M2, it was determined that the it contained the 
Streptococcus mutans non-phosphorylating NADP-dependent glyceraldehyde-3-phosphate 
dehydrogenase (GAPN) gene.  This gene was hypothesized to have the ability to improve 
cofactor balancing within the cell (Jeffries, 2006).  The H131 strain contains the XYL1 and XYL2 
genes to utilize xylose.  For each xylose molecule utilized by the cell, the xylose reductase 
(XYL1) and xylitol dehydrogenase (XYL2) enzymes consume an additional NAD(P)H and NAD+ 
which are not consumed during glucose utilization (Figure 3.19).  By incorporating the GAPN 
gene, an NAD(P)H is regenerated and the NADH which is normally utilized by the native 
glyceraldehydes-3-phosphate dehydrogenase is not consumed (Figure 3.20).  Thus, the net 
number of cofactors used would be the same as if glucose was the consumed sugar molecule.  
However, when the GAPN gene was transformed into a clean H131 background, no 
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improvement was seen.  So, a mutation probably occurred in the background which caused 
mutant M2 to have the higher xylose consumptions shown in Figure 3.18. 
 
Figure 3.19: XYL1 and XYL2 enzyme catalyzed reactions 
 
Figure 3.20: Affect of incorporating GAPN into reaction pathway 
 
 
Figure 3.21: Retransformed H131 strain with GAPN gene 
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3.3.7. Genomic DNA library of evolved strain 
The final library was used to determine the nature of the genetic modification(s) 
underlying the superior performance of strains evolved, under proper pressure, in series culturing 
or continuous cultivation experiments.  The H131-A31 strain exhibited negligible growth and 
xylose consumption rates.  After evolving it over a period of several months through growth and 
serial subculturing, strain H131E-A31 was obtained that was characterized by high growth (µ ~ 
0.2 hr-1) and high xylose consumption rates (14g/L in 2 days) (Figure 3.22 and Figure 3.23).  
Other groups have also used evolutionary strategies to generate S. cerevisiae strains which can 
consume xylose at high rates, after first transforming with the Piromyces sp. E2 xylose isomerase 
gene (Kuyper et al., 2005). 
 
Figure 3.22: Evolution of H131-A31 strain over the period of 6 months (courtesy of Hang 
Zhou).  The initial growth rate was below 0.05 hr-1 and stabilized around 0.2 hr-1 after 90 days. 
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However, the origin of improved strain performance with respect to xylose assimilation has been 
largely unknown.  In general, genome sequencing has been employed as the means of 
deciphering the nature of genetic modification(s) underlying the improvements obtained by this 
evolutionary engineering with mixed results (Ohnishi et al., 2002; Smith et al., 2008). 
 
Figure 3.23: Xylose consumption of H131-A31 (unevolved) and H131E-A31 
(evolved) strains.  H131-A31 consumed negligible amounts of xylose while 
H131E-A31 consumed 14g/L xylose after 3 days. 
 
To identify the genetic elements responsible for the improved performance of the H131E-
A31 strain, a genomic library was constructed and transformed into H131-A31.  The library was 
constructed such that each insertion had a high probability of containing at least one open 
reading frame.  Assuming that a single mutation, rather than a combination of multiple 
mutations, is sufficient to yield cells with improved xylose assimilation rate, it should be possible 
to isolate a mutant harboring a single genomic fragment by screening the cell population 
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transformed with the library with our system.  The library contained 5×105 clones; only one 
round of screening was performed to select 7.8% of the droplets.  Five clones were grown 
microaerobically in shake flasks and mutant W2 was isolated as the one having the highest 
xylose consumption rate.  The cumulative xylose consumption in the course of 4 days for a 
H131-A31 with an empty plasmid (control), the mutant W2, and H131-A31 with the plasmid 
isolated from mutant W2 (retransformed W2) was generated using biological replicates (Figure 
3.24).  Although the mutant did not consume as much xylose as the H131E-A31 strain, full 
recovery of the phenotype was not expected (Figure 3.23).  The retransformed W2 strain had a 
2.6g/L xylose consumption after 4 days of culturing compared to 4.7g/L for mutant W2 
suggesting that a background mutation also occurred in the W2 mutant. 
 
Figure 3.24: Xylose consumption of strain H131-A31 transformed with an empty plasmid 
(control), the W2 mutant, and H131-A31 harboring the plasmid isolated from mutant W2 
(retransformed W2).  Both the W2 mutant and retransformed strains have significantly higher 
xylose consumption than the control. 
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However, both consumed more xylose than the control which confirms there was a mutation on 
the plasmid which provides a benefit over the control.  DNA sequencing and restriction enzyme 
digest analysis of the plasmid from mutant W2 (pRS415-W2) was utilized to determine its 
structure (Figure 3.25).  The following describes how this analysis was performed.  DNA 
sequencing using primers complementary to the plasmid backbone and the XYLA gene construct 
allowed for the determination that the plasmid contained at least one gene construct plus two 
truncated fragments of the construct (Figure 3.26). 
 
Figure 3.25: pRS415-W2 plasmid 
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Figure 3.26: XYLA gene construct initially, in plasmid, and in evolved strain (courtesy of Hang 
Zhou).  The original construct contained the XYLA gene flanked by a promoter and terminator.  
The insertion in plasmid W2 contained 3 copies of the construct flanked by truncated constructs.  
The evolved strain (H131E-A31) contains multiple companies of the construct. 
 
Initially, the KpnI enzyme was used to digest the plasmid and confirm that the original XYLA 
gene construct existed.  These 2.2kb fragments were observed as a single band on the gel (Lane 4 
from Figure 3.28 and Table 3.2).  However, to determine how many of these constructs existed, 
an EcoRI digest was performed.  As a control, digest analysis for the original pRS415 plasmid 
was also performed using the same restriction enzymes (Figure 3.25, Lanes 1 and 3 from Figure 
3.28, and Table 3.2).  Through these analyses, the sequence of pRS415-W2 was determined to 
have three full copies of the XYLA gene construct which is flanked by truncated XYLA sequences 
(Figure 3.25 and Figure 3.26). 
 
XYLA Prom XYLA Term PromTerm
(3)
Prom XYLA Term
Original Gene Construct
Insertion in Plasmid
Prom XYLA Term
(n)
Proposed Construct in Evolved Strain
XYLA
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Figure 3.27: pRS415 plasmid 
 
Figure 3.28: Restriction enzyme digest analysis of pRS415-W2 
(Lanes 2 and 4) and pRS415 (Lanes 1 and 3) as a control.  Lanes 1 
and 2 were digested with EcoRI and lanes 3 and 4 with KpnI.  
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The exact number of copies of XYLA in H131E-A31 is unknown but it probably contained at 
least five copies which is an increase from the original number of one in H131-A31.  H131E-
A31 should contain the three full XYLA genes seen in the W2 plasmid since the gene duplication 
most likely occurred during the several month evolution as opposed to the several day growth of 
the library.  Since the truncation sites for the partial XYLA genes match the restriction enzyme 
sites for Sau3AI, the enzyme used to partially digest the DNA from the H131E-A31, larger 
pieces of the XYLA gene must have existed in that strain.  Since we have already observed 
duplication of full gene constructs, these larger pieces were most likely full constructs which 
increases the total number of copies to five. 
 
Lane in  
Figure 3.28 
1 2 3 4 
Restriction 
Enzyme 
EcoRI KpnI 
Plasmid pRS415 pRS415-geno-
(XYLAm)3 
pRS415 pRS415-geno-
(XYLAm)3 
Fragment #1 3962 bp 10,458 bp 4400 bp 5319 bp 
Fragment #2 2059 bp 3962 bp 1621 bp 2264 bp 
Fragment #3    2264 bp 
Fragment #4    2264 bp 
Fragment #5    1621 bp 
Fragment #6    688 bp 
Table 3.2: Restriction enzyme digest analysis of pRS415-W2 which describes the resulting 
fragments from EcoRI and KpnI digests 
 
The xylose isomerase gene catalyzes the reaction  
which initiates xylose assimilation by the cell. Therefore, additional copies of XYLA allowed for 
increased xylose uptake and cell growth.  As the original H131-A31 strain did not grow well on 
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xylose, the selection pressure of xylose being the sole carbon source in the medium led to the 
enrichment of cells harboring more copies of XYLA because of the growth advantage that such 
cells would enjoy in a xylose medium.  These multiple copies of XYLA were linked so they were 
created through the naturally occurring process of tandem gene duplication where recombination 
occurs between two sites which have non-identical locations.  Gene duplication occurs at 
approximately the same rate as point mutations (Zhang, 2003).  The pRS426-XYLA-XYL3 
plasmid from the H131-A31 strain contained not only the XYLA gene flanked by a promoter and 
terminator but also P. stipitis XYL3 with identical flanking regions (Figure 3.29).  These 
homologous flanking regions would allow tandem gene duplication to occur during plasmid 
replication.  Thus, the occurrence of these gene repeats is not an unexpected event. Furthermore, 
since the pRS426 plasmid is also a multicopy plasmid, its replication occurs more frequently 
than mitosis which would increase the probability of a duplication event.  The H131-A31 strain 
contained the pRS426-XYLA-XYL3 plasmid which contained identical numbers of copies of 
XYLA and XYL3.  Quantitative PCR was performed to determine the number of copies of XYLA 
and XYL3 in the H131E-A31 strain.  There were 47.9±9.0 copies of XYLA and 1.2±0.39 copies of 
XYL3.  Assuming that the number of copies of XYL3 remained constant, this result confirms that 
the number of copies of XYLA increased during evolution. 
DNA sequencing also identified a serine to tyrosine point mutation (Ser19Tyr or S19Y) in 
the xylose isomerase enzyme.  The protein crystal structure for xylose isomerase from 
Thermotoga Neapolitana (having 52% amino acid sequence identity to xylose isomerase from 
Piromyces sp. E2 that was used in the construction of strain H131-A31) has been solved.  This 
mutation occurs on the outer shell of the protein away from the active site so it is not believed to 
have affected the activity of the enzyme (Figure 3.30).  Furthermore, when a version of H131-
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A31 was created with the S19Y mutation, this strain did not have improved growth when 
compared to the strain with the unmutated XYLA.  Thus, the gene duplication of the XYLA gene 
construct was the main cause for the improved W2 strain from the library. 
 
 
Figure 3.29: pRS426-XYLA-XYL3 plasmid 
 
 
Figure 3.30: Point mutation in xylose isomerase from W2 plasmid is located on outside shell 
away from the active site 
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3.4. Conclusions 
The microfluidic high throughput screening system was successfully demonstrated to 
select for high xylose consuming yeast strains.  Initial work showed that the xylose consumption 
in a droplet was shown to approximate the consumption in a shake flask.  Furthermore, the assay 
and detection system could sufficiently differentiate between high and low xylose consuming 
strains.  A high xylose consuming strain was then enriched from a mixed population of it and a 
lower consuming strain.  This enrichment occurred even when the initial number of cells from 
the desired strain was low.  In the experiment where the initial cell concentration ratio of high to 
low xylose consuming strains was 1:10,000, two rounds of screening enriched for the high 
xylose consuming strain by over 40,000×. 
Three libraries, a putative xylose transporter gene shuffling library, a small xylose 
consuming library, and a genomic DNA library, were also screened.  Better strains than the 
control were identified in each case.  In the genomic DNA library, the plasmid from the best 
mutant was retransformed into a clean background.  The retransformed strain still consumed 
significantly higher xylose concentrations than the control, and gene duplication of the xylose 
isomerase gene was shown to be the major contributor to this beneficial phenotype.  One 
advantage of creating this genomic DNA library and being able to screen it is that it was able to 
identify a mutation which could not be found with full genome sequencing.  The genomic DNA 
is digested or sheared into short DNA segments which are subsequently sequenced, and the full 
genomic sequence is reconstructed by analyzing overlapping results.  Unless one of the 
sequencing segments were larger in size than five XYLA gene constructs, these repeats could not 
be found. 
CHAPTER 3: Screening for High Xylose Consuming Yeast Strains 
  97  
Without the use of this high throughput screening system, high xylose consuming strains 
are selected by using 10 or more rounds of serial subculturing.  This methodology typically takes 
a week or more to complete.  On the other hand, this high throughput screening platform only 
needs a single round of culturing plus 2 to 3 hours of screening to enrich a population and the 
additional time needed for more rounds of screening only increases the amount of time 
additively.  Furthermore, serial subculturing is limited to only discovering strains which have a 
growth advantage.  For example, strain 2-3 from the gene shuffling library mutant grew 
identically to the library as a whole but consumed more xylose.  Since there was no growth 
advantage for strain 2-3, serial subculturing would not be able to detect this mutant (Figure 3.31).  
Furthermore, this strain also had a higher specific xylose consumption (Figure 3.32).  Thus, if the 
goal is to find high xylose consuming strains, this system has advantages over serial 
subculturing. 
 
Figure 3.31: Cell density of strain 2-3, the entire library, and the control strain from the 
transporter library experiment 
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Figure 3.32: Maximum specific xylose consumption of strain 2-3, the entire library, and the 
control strain from the transporter library experiment 
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Chapter 4. SCREENING FOR HIGH GLUCOSE CONSUMING YEAST 
STRAINS 
 
 
 
 
4.1. Introduction 
Ideally, a screening system should be able to measure the actual metabolite of interest.  
For example, if one is looking for high ethanol producing mutants, the ethanol production by 
each clone should be quantified.  However, if the metabolite of interest cannot be measured, then 
an indirect measurement can also be used to identify desirable mutants.  In the ethanol example, 
high ethanol producing strains cannot be identified directly in the microfluidic droplet emulsion 
system because ethanol leaks out of the droplets as is described in detail in Chapter 6.  Selecting 
for high glucose consuming strains can be an alternative method for finding high ethanol 
producers.  Figure 4.1 shows a comparison of three different S. cerevisiae strains and illustrates 
how glucose consumption and ethanol production is correlated.  The ATCC 24858 strain 
consumes more glucose and also produces more ethanol while the adh1 knockout strain (adh1 
KO) consumes very little glucose and produces negligible amounts of ethanol.  PDC1-GFP is a 
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strain is a medium producing and consuming strain.  Thus, the assumption of using an indirect 
measurement of selection is valid.  In this chapter, enrichment of high glucose consuming strains 
will be demonstrated using the previously described high throughput screening system with the 
Amplex UltraRed/glucose oxidase assay system. 
 
 
Figure 4.1: Yeast strain glucose and ethanol concentrations for three strains (ATCC 24858, 
BY4741 PDC1-GFP, and BY4741 Δadh1 over the period of 9 hours. 
 
4.2. Materials and methods 
4.2.1. Yeast strain description 
The three strains used in this study are ATCC 24858, BY4741 PDC1-GFP (PDC1-GFP), 
and BY4741 Δadh1 (adh1 KO).  ATCC 24858 is an industrial polyploid S. cerevisiae strain 
(Ness, Lavallee, Dubourdieu, Aigle, & Dulau, 1993).  BY4741 PDC1-GFP is BY4741 with a 
green fluorescent protein (GFP) linked to the pyruvate decarboxylase (PDC1) gene (Huh et al., 
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2003).  BY4741 Δadh1 is the BY4741 strain with a deletion of the main alcohol dehydrogenase 
(adh1) gene (Winzeler et al., 1999). 
 
4.2.2. Shake flask fermentations 
The yeast fermentations used in this study were performed in 250mL Erlenmeyer flasks 
at 30ºC using an orbital shaker rotation speed of 225rpm.  Microaerobic fermentations were 
performed by bubbling nitrogen through the shake flask contents and sealing with a rubber 
stopper with a needle.  The culturing medium contained 6.7g/L yeast nitrogen base without 
amino acids (Difco), complete synthetic medium (MP Biomedicals) with the appropriate amino 
acid dropouts to maintain the plasmids, and 5g/L glucose. 
 
4.2.3. Droplet fermentations 
The culture medium in the droplets contained 1× yeast nitrogen base without amino acids 
(Difco), complete synthetic medium (MP Biomedicals) with the appropriate amino acid dropouts 
to maintain the plasmids, and 5g/L glucose.  Microaerobic culturing of droplets occurred at 30ºC 
in a capped 1mL syringe. 
 
4.2.4. Analytical measurements 
The microfluidic droplet screening system described in Chapter 2 was used to culture 
yeast cells in droplets, measure the remaining amount of glucose using the Amplex 
UltraRed/glucose oxidase enzyme system, and select for high glucose consuming strains. 
For the quantification of glucose and ethanol concentrations from shake flasks, cell-free 
culture supernatants were filtered through 0.2-µm-pore-size polytetrafluoroethylene membrane 
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syringe filters (VWR International).  These samples were analyzed in a high-performance liquid 
chromatography (HPLC) system with a Waters 2690 Separations module connected with a 
Waters 410 refractive index detector (Waters).  The samples were separated on a BioRad 
Aminex HPX-87H ion exclusion column for organic acid analysis with 14mM sulfuric acid as 
the mobile phase at a flow rate of 0.7mL/min.  For cell density determinations, the optical 
densities of cultures were measured at 600 nm using an Ultrospec 2100 pro UV/visible 
spectrophotometer (Amersham Biosciences). 
 
4.3. Results 
4.3.1. Glucose measurements of droplets containing glucose consuming cells 
As in the experiments for xylose consumption in Chapter 3, the glucose consumption of a 
strain cultured in a droplet can be compared to that in a shake flask.  The fluorescence 
distributions can be converted to an estimated glucose distribution by using the calibration curve 
described in Chapter 2 (Figure 2.17).  The data in these distributions were collected from 
biological replicate experiments.  The distribution of the droplets containing cells is broader than 
in the xylose experiments.  Since the glucose consumption by these strains is much faster than 
the xylose consumption of the engineered xylose strains, one hypothesis is that this higher sugar 
consumption rate is responsible for these wider distributions. 
The average glucose consumption of the ATCC 24858 strain after 3 hours is 
approximately 4g/L which is similar to the 4.3g/L shake flask glucose concentration at the same 
time point (Figure 4.1 and Figure 4.2).  A similar analysis can be performed on the BY4741 
PDC-1 GFP strain.  After culturing for 7 hours, the average glucose concentration in the droplet 
is 3g/L which approximates the shake flask concentration of 3.4g/L (Figure 4.1 and Figure 4.3). 
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Figure 4.2: Estimated glucose concentration distribution from ATCC 24858 droplet culture after 
3 hours.  The average glucose consumption by the droplets with cells was 4g/L. 
 
Figure 4.3: Estimated glucose concentration distribution from BY4741 PDC1-GFP droplet 
culture after 7 hours.  The average glucose consumption by the droplets with cells was 3g/L. 
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By culturing the individual strains and analyzing the fluorescence detection data at different time 
points, it can be determined if the screening system can differentiate the strains.  Figure 4.4 
shows the percentage of droplets with fluorescence values less than 0.6 from the three yeast 
strains analyzed over the period of several hours.  The values were calculated for each time point 
and show an identical glucose consumption trend to that shown in Figure 4.1, which is the 
measurement from the shake flask experiments.  The trend shows that the strains in order of 
fastest to slowest consumption are ATCC 24858, BY4741 PDC1-GFP, and BY4741 Δadh1. 
 
Figure 4.4: Comparison of percentage of droplets with fluorescence values less than 0.6 for the 
three different strains.  As expected, the highest to lowest consuming strains are ATCC 24858, 
BY4741 PDC1-GFP, and BY4741 Δadh1. 
 
4.3.2. BY4741 PDC1-GFP vs. BY4741 Δadh1 strain enrichment 
The BY4741 PDC1-GFP strain was enriched from an equal proportion mixture of it and 
the BY4741 Δadh1 strain.  Before performing the actual enrichment experiment, each strain was 
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grown separately in droplets for 7 hours with biological replicates, and the resulting fluorescence 
data for the percentage of droplets in different fluorescence ranges was analyzed (Figure 4.5).  
There is a statistical difference between the two strains for the data in the 0-0.5, 0-0.6, and 0-0.7 
ranges.  The percentage ratio for a bin range is the ideal enrichment of PDC1-GFP when there is 
no sorting error.  The highest ratios for the statistically significant ranges are 0-0.5 and 0-0.6.  
Thus, these ranges were chosen as the sorting thresholds for the enrichment experiment.  The 
cells for the enrichment study were cultured for 7 hours (Figure 4.6).  The enrichment due to 
growth was almost 19× because the PDC1-GFP strain grows much faster than the Δadh1.  
Sorting improved this enrichment by additional 3× for a total enrichment of 54×. 
 
Figure 4.5: BY4741 PDC1-GFP and BY4741 Δadh1 strains after 7 hour culture.  The two 
strains are statistically different in the 0-0.5, 0-0.6, and 0.7 ranges (* - p < 0.05). 
 
*
*
*
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Figure 4.6: Enrichment of BY4741 PDC1-GFP after 7 hour culture from initial 1:1 BY4741 
PDC1-GFP/BY4741 Δadh1 mixture.  The growth enrichment is 19× and sorting droplets in 0-0.6 
range increases enrichment up to 54×. 
 
4.3.3. ATCC 24858 vs. BY4741 PDC1-GFP strain enrichment 
A second enrichment experiment for a ATCC 24858 and BY4741 PDC1-GFP mixture 
was performed.  Analysis of the detection data when culturing each strain separately shows that 
the less than 0.3 through 0.7 fluorescent ranges all show a statistically significant difference 
between the two strains (Figure 4.7).  Furthermore, the 0-0.4 bin range shows the highest amount 
of ideal enrichment and was chosen as the range used in the actual sorting experiment which 
enriched for the ATCC 24858 strain by over 6×.  It was also observed that there was no growth 
contribution to the enrichment (Figure 4.8). 
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Figure 4.7: ATCC 24858 and BY4741 PDC1-GFP strains after 4 hour culture.  The two strains 
are statistically different in all ranges (* - p < 0.05). 
 
Figure 4.8: Enrichment of ATCC 24858 after 4 hour culture from initial 1:1 ATCC 
24858/BY4741 PDC1-GFP mixture.  There is no growth enrichment and sorting droplets in 0-
0.4 range increases enrichment up to 6×. 
*
* * * *
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4.4. Conclusions 
The microfluidic high throughput screening system has been demonstrated to be truly 
flexible since both high glucose and xylose consuming strains can be identified.  Glucose can be 
measured by the simple substitution of the glucose oxidase enzyme into the assay system.  Thus, 
any oxidase enzyme can be utilized in this platform to select for high consuming or producing 
strains. 
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Chapter 5. SCREENING FOR HIGH XYLOSE CONSUMING BACTERIAL 
STRAINS 
 
 
 
 
5.1. Introduction 
Escherichia. coli has been engineered to produce ethanol by incorporating the alcohol 
dehydrogenase II and pyruvate decarboxylase genes from Zymomonas mobilis (Ingram, Conway, 
Clark, Sewell, & Preston, 1987).  Unlike Saccharomyces cerevisiae, native E. coli has the ability 
not only to utilize hexose sugars but also pentose sugars, such as xylose, which are a significant 
component of lignocellulosic feedstocks (Chundawat et al., 2007).  Thus, E. coli is a suitable 
organism for cellulosic biofuels production.  However, the ethanol tolerance of E. coli is less 
than that for S. cerevisiae, and high ethanol tolerance is important for the production of high 
concentrations of ethanol (Zaldivar, Nielsen, & Olsson, 2001).  Improving ethanol tolerance has 
also been shown to improve ethanol production and is a simple phenotype to screen (Alper & 
Stephanopoulos, 2007; Yomano, York, & Ingram, 1998).  However, if improved ethanol 
production is the main phenotype of interest, it is better to select for high ethanol producers 
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directly.  There are some fundamental challenges for measuring ethanol in droplets as will be 
described in Chapter 6.  An alternate method is to identify strains with high sugar consumption, 
which correlates to high ethanol production (Yomano et al., 1998).  For example, Figure 5.1 
shows a strong xylose consumption to ethanol production correlation for strains from a previous 
E. coli rpoA library. 
 
Figure 5.1: Xylose consumption vs. ethanol production correlation 
 
Global transcription machinery engineering (gTME) has been used to find strains of yeast 
exhibiting high ethanol tolerance and productivity as well as E. coli strains with high tolerance 
(Alper, Moxley et al., 2006; Alper & Stephanopoulos, 2007).  In gTME, diverse error-prone PCR 
libraries of proteins which affect DNA to RNA transcription are created and screened to identify 
mutants with the most desired phenotype.  When investigating complex phenotypes, gTME can 
be a more useful tool than the traditional methods of deleting or overexpressing genes because 
the mutated factors can affect the transcription of more than one gene.  For bacterial gTME, 
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libraries of rpoA, the α subunit of the RNA polymerase, and rpoD, the main sigma factor σ70, 
have been studied (Alper & Stephanopoulos, 2007; Klein-Marcuschamer & Stephanopoulos, 
2008).  The RNA polymerase holoenzyme consists of the core RNA polymerase, which contains 
the α, β, and β’ subunits, and the sigma factor (σ) (Watson et al., 2004).  Transcription is 
initiated when the RNA polymerase recognizes and binds to a promoter region sequence on the 
DNA.  The C-terminal subunit of the α subunit binds to the UP-element while the sigma factor 
binds to the -35 and -10 regions (Figure 5.2).  Thus, by mutating the sequences in rpoA and rpoD 
which code for the amino acids that bind to the DNA, the RNA transcript levels of various genes 
can be modified. 
 
Figure 5.2: E. coli RNA polymerase 
 
The most industrially relevant application for the production of ethanol is to identify 
strains which produce high amounts of ethanol in lignocellulosic hydrolysates.  These 
hydrolysates contain inhibitory compounds as well as high xylose concentrations which affect 
the growth and ethanol production of E. coli (Almeida et al., 2007).  However, because this type 
of medium is dark and opaque, it can be difficult to perform assays on the extracellular 
metabolites.  Thus, one way to identify high ethanol producing E. coli strains grown in a 
hydrolysate medium is to perform a two-step process of first identifying cells which survive the 
harsh medium and then selecting for high xylose consuming strains in a minimal medium. 
αCTD
αNTD
σ
β’ β
‐10‐35UP
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5.2. Materials and methods 
5.2.1. Strains 
The parental strain used in these experiments was XZ030 which was provided by 
Verenium Corporation.  This strain is similar to the KO11 strain (Yomano et al., 1998).  Error-
prone PCR was used to create the rpoA and rpoD libraries.  The rpoA and rpoD libraries were 
contructed using plasmids pCL1920 and pHACM, respectively.  The mutations for the rpoA 
library were targeted to the C-terminal domain. 
 
5.2.2. Fermentations and media 
The E. coli microaerobic fermentations used in this study were performed with 5.5mL of 
medium in KingFisher 24-well deep well plates (Thermo Fisher) covered with aluminum foil at 
35ºC using an orbital shaker rotation speed of 225rpm.  All culture medium contained the 
appropriate antibiotics to maintain the plasmids, and the desired concentration of xylose.  The 
rich culturing medium contained overlimed hydrolysate from sugar cane at pH 6.5 with 5% corn 
steep liquor and a total of 140g/L xylose.  The minimal medium was AM1 with 30g/L ethanol 
and either 10 or 20g/L xylose (Martinez et al., 2007).  Microaerobic culturing of cells in droplets 
occurred at 37ºC in a capped 1mL syringe. 
 
5.2.3. Pre-screening of library 
The rpoA library was pre-screened before microfluidic droplet screening by growing cells 
in overlimed hydrolysate from sugar cane at pH 6.5 with 5% corn steep liquor, 100g/L xylose, 
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and 80g/L ethanol for 4 hours.  The rpoD library was prescreened in a similar manner except 
50g/L ethanol was used and the cells were exposed to that environment for 6 hours. 
 
5.2.4. Analytical measurements 
The microfluidic droplet screening system described in Chapter 2 was used to culture the 
bacterial cells in droplets, measure the remaining amount of xylose using the Amplex 
UltraRed/pyranose oxidase enzyme system, and select for high xylose consuming strains. 
For the quantification of xylose concentrations from shake flasks, cell-free culture 
supernatants were filtered through 0.2-µm-pore-size polytetrafluoroethylene membrane syringe 
filters (VWR International).  These samples were analyzed in a high-performance liquid 
chromatography (HPLC) system with a Waters 2690 Separations module connected with a 
Waters 410 refractive index detector (Waters).  The samples were separated on a BioRad 
Aminex HPX-87H ion exclusion column for organic acid analysis with 14mM sulfuric acid as 
the mobile phase at a flow rate of 0.7mL/min.  For cell density determinations, the optical 
densities of cultures were measured at 600 nm using an Ultrospec 2100 pro UV/visible 
spectrophotometer (Amersham Biosciences). 
 
5.3. Results 
5.3.1. Ensuring single cells in droplets 
Since single E. coli cells are difficult to visualize on an optical microscope, an E. coli 
strain which expressed a superfolder green fluorescent protein was used to determine the optimal 
incoming cell density to ensure that there is one cell in every 2-3 droplets (Pedelacq, Cabantous, 
Tran, Terwilliger, & Waldo, 2006).  The high emitted fluorescence of this strain allowed for low 
CHAPTER 5: Screening for High Xylose Consuming Bacterial Strains 
  114  
magnification imaging of the cells in droplets which was necessary because the droplets were 
75μm in diameter while the cells were only 1μm wide and several microns long.  By visualizing 
the cells and droplets simultaneously on a microscope, the optimal cell density was determined 
to be OD600 = 0.003. 
 
5.3.2. Culturing medium compatibility with assay system 
The bulk cultures were performed in a rich medium with 140g/L xylose.  The Amplex 
UltraRed/pyranose oxidase enzyme system is not compatible with a rich medium since they 
contain compounds which will react with the horseradish peroxidase enzyme to produce a high 
background signal.  Furthermore, the medium is also opaque which may cause problems during 
the fluorescence detection.  Thus, a minimal medium must be used to culture the cells in the 
screening system.  The AM1 minimal medium had been developed to culture ethanologenic 
bacterial strains and was used to culture cells in droplets (Martinez et al., 2007).  Furthermore, 
140g/L xylose is difficult to measure in the assay system.  At high xylose concentrations, the 
fluorescence intensity decreases.  The pyranose oxidize enzyme concentration can be decreased 
to a level which causes the fluorescence to increase or remain constant at high xylose 
concentrations.  However, the peak to background fluorescence ratio becomes significantly 
lower than the ideal ratio of 10.  Thus, it was determined that an initial 20g/L xylose 
concentration is the highest concentration which is compatible with the assay system.  Since 
140g/L xylose also provides stress to the cells, 30g/L ethanol was added to the culturing medium 
as a different stress to the cells.  To ensure that high xylose consumers in the rich medium with 
140g/L xylose perform similarly in minimal medium with 20g/L xylose and 30g/L ethanol, five 
strains from an rpoA library were cultured in both media for 72 hours and the xylose 
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consumption was measured (Figure 5.3).  There was good correlation between the two types of 
media. 
 
Figure 5.3: Xylose consumption by various rpoA library strains in rich and minimal media.  The 
High xylose consumers in rich medium also have high xylose consumption in minimal medium. 
 
5.3.3. Screening rpoA library and characterizing strains 
The rpoA library contained 5×105 colonies.  To reduce the size of the library, it was 
prescreened before microfluidic droplet screening by growing cells in overlimed hydrolysate 
from sugar cane at pH 6.5 with 5% corn steep liquor, 100g/L xylose, and 80g/L ethanol for 4 
hours.  The resulting library contained 4.2×104 colonies after the stress.  These colonies were 
screened in the microfluidic droplet system with a 60.5 hour culturing time using the AM1 
minimal medium with 10g/L xylose and 30g/L ethanol, which was added as a stress for the cells, 
and 14.2% of the droplets were selected.  Sixty of the selected clones were cultured for 72 hours 
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in 24-well deep well plates using the overlimed hydrolysate/corn steep liquor rich medium 
mixture which contained 140g/L xylose. 
 
Figure 5.4: Xylose consumption of 60 rpoA mutants and control in rich medium after 72 hrs. 
 
Figure 5.5: Ethanol production of 60 rpoA mutants and control in rich medium after 72 hrs. 
CHAPTER 5: Screening for High Xylose Consuming Bacterial Strains 
  117  
The control, which contained a plasmid with the wild type rpoA, consumed 104.3g/L 
xylose and produced 46g/L ethanol on average.  The best mutant had a 113.6g/L xylose 
consumption and a 48.9g/L ethanol production, which are 8.9% and 6.3% higher than the control 
average (Figure 5.4 and Figure 5.5).  The horizontal black line in the graphs is the average 
concentration of the control strain.  Furthermore, 93.7% of the 60 mutants had higher xylose 
consumption and ethanol production than the control. 
 
Figure 5.6: Xylose consumption of 20 rpoA mutants and controls 
in minimal medium after 72 hrs. 
 
Twenty of the selected rpoA mutants where also grown microaerobically in AM1 
minimal medium with 20g/L xylose and 30g/L ethanol for 72 hours.  In this experiment, the 
controls contained the plasmid with no insertion (pCL1920) or the wild type rpoA 
(pCL1920/rpoA), and all of the strains exhibited higher xylose consumption than the controls.  
The xylose consumption by the selected mutant population was 6.2±0.3g/L while it was 
2.0±0.1g/L for the strain with the blank plasmid and 0.2±0.1g/L for the strain with the plasmid 
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containing the wild type rpoA (Figure 5.6).  Since significant amounts of ethanol were a 
component in the medium, there was no difference in the ethanol concentrations for the different 
strains. 
 
5.3.4. Screening rpoD library and characterizing strains 
The rpoD library was prescreened in a similar manner as the rpoA library except 50g/L 
ethanol was used and the cells were exposed to that environment for 6 hours.  After performing 
droplet screening in the same manner as the rpoA library and selecting 2.6% of the droplets, 
twenty strains were cultured in deep well plates for 72 hours.  The best strain consumed 109.5g/L 
xylose and produced 47.8g/L ethanol while a strain an extra wild type rpoD on a plasmid 
consumed 109.7g/L xylose and produced 47.3/L ethanol.  In this case, the best strain was 
identical to the control. 
 
Figure 5.7: Xylose consumption of 20 rpoD mutants and controls 
in minimal medium after 72 hrs. 
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However, when twenty of the strains were grown for 72 hours in AM1 minimal medium 
with 20g/L xylose and 30g/L ethanol, nineteen of these strains had considerably higher xylose 
consumption than the controls (Figure 5.7).  The two control strains contained a plasmid with no 
insertion (pHACM) or with the wild type rpoD (pHACM/rpoD).  These results are similar to 
those observed in the rpoA experiment.  Excluding strain D14, the xylose consumption of 
screened strain population was 4.2±0.5g/L while the controls were 2.3±0.1g/L and 2.1±0.0g/L 
for the blank plasmid and wild type rpoA strains, respectively.  Since significant amounts of 
ethanol were a component in the medium, there was no difference in the ethanol concentrations 
for the different strains. 
 
5.4. Conclusions 
It has been demonstrated that E. coli strains can also be screened with the high 
throughput screening system without any modifications other than to optimize the incoming cell 
density.  Screening the rpoA library identified a slightly higher xylose consuming and ethanol 
producing strain as confirmed with a bulk culture using a sugar cane overlimed hydrolysate/corn 
steep liquor mixture.  Furthermore, almost all of the strains tested had an improved phenotype 
compared with the control.  However these increases were not significant in a practical sense.  
The rpoD library selection did not find any improved mutants using these same bulk culturing 
conditions.  However, when the selected strains were grown in the minimal medium used in the 
droplet culturing, all of the rpoA strains and 95% of the rpoD strains consumed significantly 
higher xylose than the controls.  Thus, the strains selected from the libraries perform better than 
the controls when they are tested in the same minimal medium conditions as was used in the 
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screening process while little or no difference was observed between the selected strains and the 
controls when they were tested in a different culture medium. 
 
 
CHAPTER 6: Ethanol Detection in Microfluidic Droplets 
  121  
 
 
 
 
Chapter 6. ETHANOL DETECTION IN MICROFLUIDIC DROPLETS 
 
 
 
 
6.1. Introduction 
Ethanol is an important chemical because of its use as a biofuel.  Recently, much 
development has occurred in the area of biofuels for environmental, economic, and geopolitical 
reasons.  Since these fuels use renewable feedstocks, their net carbon dioxide output is lower 
than that for traditional petrochemical fuels because these feedstocks utilize photosynthesis and 
thus consume carbon dioxide.  Currently, our major liquid fuel source is gasoline which is a 
product of the crude oil refining process.  The price for a barrel of crude oil has increased from 
$25 in 2003 to a peak of almost $150 in mid-2008.  While prices have dropped back to 
$50/barrel recently, the uncertainty of petroleum prices has also increased the desire to have 
more control over energy costs such as through the use of biofuels.  In addition, a higher price 
for gasoline means that ethanol fuel is more cost competitive.  Biofuels also allow for the United 
States to have a more stable energy supply by being less dependent on foreign countries, some of 
which have unstable governments (Stephanopoulos, 2007). 
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The main organism for ethanol production is Saccharomyces cerevisiae which readily 
produces ethanol.  It has been shown that the productivity of strain can be increased if it has a 
higher tolerance for ethanol and glucose (Alper, Moxley et al., 2006).  The strain identified in 
this study was isolated from a library by selecting for mutants with high ethanol and glucose 
tolerances.  However, this assumes that all high ethanol producing mutants also have high 
tolerance which may not true.  Utilizing a high throughput screening system to directly measure 
the ethanol production of clones from a library is the most efficient method for identifying high 
ethanol producing strains. 
 
6.2. Materials and methods 
6.2.1. Alcohol oxidase ethanol assay 
Ethanol was detected fluorescently using the chemicals Amplex Red (Invitrogen), 
horseradish peroxidase (Sigma), and alcohol oxidase from Picha pastoris (Sigma). 
 
6.2.2. Oils and surfactants 
FC-40, perfluorodecalin, mineral oil, silicone oils, and perfluorooctylbromide (PFOB) 
were all purchased from Sigma.  FC-72, FC-75, FC-77 were purchased from Acros.  AEH19 and 
AEH24 surfactants were supplied by Andrew Griffiths’ laboratory. cE2K0420 and cE2K0665 
were provided by Raindance Technologies. 
 
6.2.3. Assay in 96 well plates 
Unless otherwise noted, all 96 well plate measurements were performed using 20µL each 
of three components: 0.188U/mL alcohol oxidase, 3-LoAR (containing 4.02mL 1× phosphate 
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buffered saline (PBS), 25µL 10mM Amplex Red dissolved in DMSO, and 125µL 10U/mL 
horseradish peroxidase), and the sample.  The assay reaction time was 5 minutes.  It was 
discovered that the alcohol oxidase reacts with the 2% AEH24 surfactant, but it does not react 
with the HRP.  cE2K0420, cE2K0665, and AEH19 do not react with either enzyme. 
 
6.2.4. Assay in water/oil droplets 
The same mixture of chemicals was used for performing the assay in droplets except that 
1 or 5U/mL alcohol oxidase was used because of the issue described in Section 2.5.2. 
 
6.2.5. Analytical measurements 
To quantify the ethanol concentrations, cell-free culture supernatants were filtered 
through 0.2-µm-pore-size polytetrafluoroethylene membrane syringe filters (VWR International) 
and used for high-performance liquid chromatography (HPLC) analysis of the sample was 
performed with a Waters 2690 Separations module connected with a Waters 410 refractive index 
detector (Waters).  The samples were separated on a BioRad Aminex HPX-87H ion exclusion 
column for organic acid analysis with 14mM sulfuric acid as the mobile phase at a flow rate of 
0.7mL/min. 
 
6.2.6. Shake flask fermentations 
The yeast fermentations used in this study were performed in 250mL Erlenmeyer flasks 
at 30ºC using an orbital shaker rotation speed of 225rpm.  All fermentations were performed 
aerobically by placing a porous sponge in the flask opening.  The medium contained 1× yeast 
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nitrogen base without amino acids (Difco), complete synthetic medium (MP Biomedicals) with 
the appropriate amino acid dropouts to maintain the plasmids, and 20g/L glucose (Sigma). 
 
6.3. Ethanol detection 
6.3.1. Ethanol assay in 96 well plates 
The assay system for measuring ethanol is similar to that used for detection of xylose and 
glucose except that Amplex Red is used as the chemical which is converted to resorufin.  Below 
is the assay reaction: 
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However, an undesired reaction occurs because the Amplex Red molecule contains two alcohol 
groups (Figure 6.1).  It reacts with the alcohol oxidase to produce additional H2O2 which 
converts, additional Amplex Red to resorufin. 
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Figure 6.1: Chemical structure of Amplex Red 
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To reduce the fluorescence observed on samples without ethanol (e.g., the background 
signal), both the Amplex Red and alcohol oxidase concentrations can be decreased (Figure 6.2).  
Higher alcohol oxidase enzyme concentrations lowered the ethanol detection limit while lower 
enzyme concentrations decreased the background signal and increased the dynamic range 
(Figure 6.2, Figure 6.3, and Figure 6.4).  The detection limit was calculated as three times the 
standard deviation for the samples without ethanol.  Amplex UltraRed was not used in this assay 
because it produced an extremely high fluorescence when no ethanol was in the sample. 
Cell culture supernatant samples from the BY4741 S. cerevisiae strain were taken from 5 
different culturing conditions with biological replicates.  Each condition had a different initial 
glucose concentration: 2, 5, 10, 15, and 20g/L.  Samples were taken after a 24 hour culture time 
and were diluted by 167× so that the ethanol could be measured using Amplex Red fluorescent 
ethanol assay with 1.5U/mL alcohol oxidase.  Figure 6.5 shows that the HPLC and Amplex Red 
assay measurements correlate well.  The undiluted concentrations are reported in the graph. 
 
Figure 6.2: Effect of Amplex Red and alcohol oxidase concentrations on 
the resorufin fluorescence of samples without ethanol 
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Figure 6.3: Effect of Amplex Red and alcohol oxidase 
concentrations on the ethanol detection limit 
 
Figure 6.4: Ethanol calibration curves for Amplex Red ethanol 
assay with 1.5U/mL and 3.75U/mL alcohol oxidase 
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Figure 6.5: Correlation of HPLC and fluorescent assay measurements of 
ethanol from yeast cell culture supernatants 
 
6.3.2. Ethanol assay in droplets 
Calibration curves for ethanol detection were generated by using a droplet making device 
with delay lines, which similar to the one in Figure 2.14 except that there were three inputs since 
the assay solution was separated into one containing only alcohol oxidase and the other 
contained Amplex Red and HRP.  In this device, a known amount of ethanol is mixed with the 
assay directly before droplet formation.  The oil surfactant combination in this experiment was 
FC-40 and cE2K0420 as the oil/surfactant combination.  The fluorescence was measured at the 
end of the device.  The resulting calibration curve for 1U/mL alcohol oxidase is linear up to 
5mM and that for 5U/mL is linear up to 10mM (Figure 6.6 and Figure 6.7).  The values on these 
curves are the mean fluorescence values as measured by the detection system. 
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Figure 6.6: Ethanol calibration curve with 5U/mL alcohol oxidase 
 
 
Figure 6.7: Ethanol calibration curve with 1U/mL alcohol oxidase 
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6.4. Initial ethanol leakage experiments 
Several attempts were made to culture yeast cells in droplets and measure the resulting 
ethanol concentration, but the fluorescence of droplets with cells and those without were 
identical.  It was then hypothesized that ethanol leaks out of the droplets using the FC-40 and 
cE2K0420 oil/surfactant combination, and two tests were performed.  The first was one in which 
separate emulsions of ethanol and the assay were created using vortexing.  These two emulsions 
were combined without intentional mixing for 5 minutes, and fluorescence was seen which 
meant that ethanol moved into the assay droplets.  Several other fluorinated (FC-72, FC-75, FC-
77, and perfluorodecalin), hydrocarbon, and silicone oils were tested, and all had the same 
leakage problem.  The second test was one in which the device shown in Figure 6.8 was used but 
without applying the electrical field for coalescence. 
 
Figure 6.8: Coalescence with detection device which reinjects droplets and also creates assay 
droplets, coalesces the two types of droplets together, allows the assay reaction to proceed, and 
resulting fluorescence can be measured. 
Reinjection
Coalescence
Delay Lines
Assay
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In this device, alternating droplets with the assay and with ethanol flowed through the channels.  
Two experiments were performed in which the reinjected droplets contained either no ethanol or 
30mM ethanol and the resulting fluorescence in the droplets was measured (Figure 6.9).  If there 
was no leakage, the fluorescence distributions from the two experiments should be the same.  
Since the 30mM ethanol experiment had a higher fluorescence than the one with no ethanol, it 
was determined that ethanol leaked into the assay droplets created with FC-40 with cE2K0420 
which matches the results from the first test. 
.  
Figure 6.9: Microfluidic leakage test which shows the fluorescence distributions of assay 
droplets which alternate with droplets containing no ethanol or 30mM ethanol. 
 
6.5. Ethanol leakage experiments performed in Strasbourg 
Additional experiments were performed in Andrew Griffiths’ laboratory in Strasbourg, 
France to attempt to solve the leakage issues. 
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6.5.1. Yeast strain comparison at 1 hour 
To determine the how well yeast grew and produced ethanol in several surfactants, the BY4741 
PDC1-GFP and TurboYeast strains were cultured anaerobically in 2mL microcentrifuge tubes 
containing manually vortexed emulsions.  Three surfactants in FC-40 were used: 1.8% 
cE2K0420, 2% AEH19 and 0.5% AEH24.  All cultures were started at OD~3 in medium 
containing CSM + YNB + 20g/L glucose (uracil was added).  Table 6.1 shows that there was no 
significant growth of the cells after 1 hour.  Figure 6.10 shows that the two yeast strains did 
produce around 5mM ethanol after one hour.  As expected, TurboYeast also produced more 
ethanol than the PDC1-GFP strain. 
Cell Density (OD600) 
Strain Surfactant 0hr 1hr 
TurboYeast cE2K0420 1.8% 2.94 3.98 
TurboYeast AEH19 2% 2.94 3.34 
TurboYeast AEH24 0.5% 2.94 2.54 
PDC1-GFP cE2K0420 1.8% 2.85 3.36 
PDC1-GFP AEH19 2% 2.85 3.1 
PDC1-GFP AEH24 0.5% 2.85 2.14 
Table 6.1: Cell growth of anaerobic yeast culture in manually vortexed droplets 
 
Figure 6.10: Ethanol produced during a 1 hour anaerobic yeast culture in manually vortexed 
droplets with three types of surfactants (1.8% cE2K0420, 2% AEH19, and 0.5% AEH24) 
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6.5.2. Double coflow device leakage measurement 
A double coflow device similar to the one shown in Figure 6.8 was used to measure the 
ethanol leakage in droplets generated in a microfluidic device.  FC-40 with 2% AEH19 was used 
as the oil phase.  Two types of droplets were formed: one which contained the assay reagents (3-
LoAR + 1U/mL alcohol oxidase) and another which contained either PBS or 10mM ethanol in 
PBS.  After generating the droplets, PTFE tubing was used as a ~5 minute delay line.  The 
droplets were reinjected into a device in which resorufin fluorescence was measured.  There was 
a higher detected fluorescence in the experiment with ethanol droplets (Figure 6.11).  Thus, 
ethanol leakage was observed. 
 
Figure 6.11: Microfluidic ethanol leakage measurement which shows the 
fluorescence distributions of assay droplets which alternate with droplets 
containing no ethanol or 30mM ethanol 
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6.5.3. Bulk leakage measurement in tubes 
A bulk ethanol leakage measurement was performed using the setup shown in Figure 
6.12.  A 1cm diameter glass tube was bent into the shape shown.  1mL of the oil was pipetted 
into the tube on the “EtOH” side.  1mL each of the PBS and ethanol were pipetted 
simultaneously into the tube.  20µL samples of the PBS were taken to quantify the ethanol 
leakage using the fluorescent assay system. 
 
Figure 6.12: Bulk leakage measurement setup using a glass tube bent into a U-shape.  Samples 
of PBS are taken to determine if ethanol has diffused through the oil. 
 
The first experiment using this setup was used to determine if there was a difference in 
the ethanol leakage when oil was used with or without surfactants.  Figure 6.13 shows that after 
two hours, the sample which had significant amounts of ethanol leakage was the one with FC-40 
only and 1% ethanol in PBS.  After 17.5 hours, all of the experiments except for the FC-40 with 
2% AEH19 surfactant and 1% ethanol in PBS had a significant amount of ethanol leakage. 
Since it seemed that having a surfactant reduced the leakage, a second experiment was 
performed.  Various fluorinated or brominated oils without a surfactant were tested to determine 
which oil was best for preventing leakage.  The ethanol sample contained 1% ethanol in PBS. 
Oil
PBS EtOH
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Figure 6.13: Ethanol leakage test in FC-40 using set-up shown in Figure 6.12 where a sample of 
the PBS was measured with the fluorescent assay to determine if ethanol diffused through the oil 
 
Figure 6.14: Leakage test of various oils using set-up shown in Figure 6.12 where a sample of 
the PBS was measured with the fluorescent assay to determine if ethanol diffused through the oil 
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Figure 6.14 shows that FC-40 and the fluorotriethylamine oils had significant ethanol leakage 
even after 1 hour.  Perfluorooctyl bromide (PFOB) had the least amount of leakage and even 
after 22.5 hours, the leakage was below 1mM.  Even though promising results were observed for 
PFOB, a manual vortex experiment using 2% AEH19 in PFOB, 3-LoAR, 5U/mL alcohol 
oxidase, and 5mM ethanol had much leakage. 
 
6.5.4. NMR results 
Nuclear magnetic resonance (NMR) can be measure the solubility of a chemical in a 
solvent.  Samples were prepared by mixing ethanol and glucose in water, FC-40, and PFOB in a 
1:100 ratio.  A sample of the solvent was then measured on an NMR machine.  Glucose was only 
detected only in the water sample while ethanol was detected in all samples. 
 
6.6. Conclusions 
It was reported that ethanol is soluble in the FC-40 oil at 8.5mM which confirms our 
results (Li et al., 2006).  Since ethanol leaks even in oils such as PFOB, further work to develop 
the system for measuring ethanol production was not pursued further.  While being able to detect 
ethanol production directly would be an important tool, the leakage of ethanol is a technically 
challenging problem to solve.  It is caused directly by the fact that ethanol is slightly soluble in 
the oil phase which permits ethanol from a droplet to leak into the oil phase.  Since the solubility 
is much higher in the aqueous phase, ethanol will partition back into the aqueous phase such as a 
different droplet.  Thus, ethanol can easily transfer from droplet to droplet.  There are two 
physical chemists in Andrew Griffiths’ laboratory at Strasbourg who are continuing to work on 
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this issue further.  If the leakage can be slowed but not completely prevented, one possibility for 
detecting ethanol production by yeast cells in droplets is to assay for ethanol at the beginning of 
the culture.  This can be performed by adding the assay chemicals into the droplet at the same 
time as the culture medium.  If the assay reaction consumes ethanol quicker than the cell can 
produce it, the leakage could be minimized. 
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Chapter 7. ASSAYS FOR AMINO ACID DETECTION 
 
 
 
 
7.1. Introduction 
Several assay systems were developed for the detection of the amino acids tyrosine and 
L-aspartic acid.  These amino acids were chosen because both chemicals have consumer and 
industrial applications.  Tyrosine can be used as a dietary supplement as well as a precursor for 
specialty chemicals such as L-dopa, which can be used to treat Parkinson’s disease, and the 
monomer p-hydroxystyrene used in creating industrial polymers (Bongaerts, Kramer, Muller, 
Raeven, & Wubbolts, 2001; Qi et al., 2007).  Tyrosine has been produced at 9.1g/L levels using 
microbial fermentations (Lutke-Eversloh & Stephanopoulos, 2007).  Aspartic acid is one of the 
top twelve candidates in the DOE “Top Value Added Chemicals from Biomass” document 
(Werpy & Peterson, 2004).  It is primarily used as a component in the commonly used sweetnet 
aspartame.  However, very little work has been performed to use fermentation processes to 
produce aspartic acid even though the sugar feedstock for a fermentation process is cheaper than 
what is used in the current enzymatic processes. 
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Typical methods for measuring these amino acids, such as HPLC, last about 15 minutes 
per measurement.  Developing faster measurements is critical to being able to measure a large 
number of samples or to perform higher throughput screening.  Furthermore, it is also 
advantageous if the same technique could be used to monitor a fermentation process.  The 
enzyme electrode and fluorescent enzymatic assay metabolite detection techniques were 
evaluated to determine if they had sufficient speed or could be applied to a cell culture system.  
Both of these measurement methods are enzyme-based because of the enzymes inherently have 
high specificity to the metabolite of interest. 
 
7.2. Materials and methods 
7.2.1. Tyrosine enzyme electrodes 
Tyrosine enzyme electrodes were fabricated using the following chemicals: tyrosinase 
(from mushroom) (Sigma), polyvinylimidazole (PVI) (GFS Chemicals), poly(ethylene glycol) 
(400) diglycidyl ether (PEGDGE) (Polysciences), and Nafion 117 (Fluka).  A CH Instruments 
800B electrochemical detector measured the electrical current output from applying a +0.18V 
Ag/AgCl voltage to a system consisting of a 1mm glassy carbon electrode sealed with PEEK as 
the working electrode, a miniature Ag/AgCl reference electrode (Cypress Systems) as the 
reference electrode, and a platinum wire (Alfa Aesar) as the counter electrode.  Phosphate buffer 
solution (PBS) (Mediatech) was used to dilute the enzyme and measurement solutions. 
A tyrosine enzyme with polymer solution was created by combining 5μL of 5mg/mL 
tyrosinase in PBS, 10μL of 5mg/mL PVI dissolved in PBS, and 2μL of 4mg/mL PEGDGE 
dissolved in water.  A tyrosine enzyme electrode was formed by adding 4μL of the 
tyrosine/polymer solution to the glassy carbon electrode and allowing the solution to dry 
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overnight.  To add a Nafion film to the electrode, 5μL of either 0.25% or 0.5% Nafion dissolved 
in ethanol was added to the electrode and allowed to dry overnight.  Electrodes were stored in a 
PBS solution. 
All calibration solution measurements were performed by diluting a tyrosine stock 
solution in PBS.  Samples from cell cultures were also diluted in PBS 
 
7.2.2. L-aspartate oxidase synthesis 
PCR was used to make copies of the Pyrococcus horikoshii L-aspartate oxidase gene by 
using the P. horikoshii genomic DNA obtained from ATCC as the template.  The primers used 
were AGAGGAGAGTTAGAGCCCCACCTAGATTGAAATGGTAAG (sense) and GGTATTG 
AGGGTCGCATGATGGAGATGAGGGTTGG (antisense).  The PCR product was ligated to a 
Novagen pET30 Xa/LIC vector and transformed into a NovaBlue cloning host.  DNA 
sequencing on the resulting plasmids was performed to confirm the sequence.  A BL21(DE3) 
expression host was transformed using the aforementioned plasmid and was induced with 
0.4mM isopropyl-β-D-thiogalctopyranoside (IPTG) to express the nadB gene via the lac 
promoter.  The aspartate oxidase produced contains the appropriate amino acids in order for the 
enzyme to be His-tag purified.  This purification was performed using a Novagen His-Bind kit.  
To confirm the purity of the enzyme, a sample was analyzed on an SDS-Page using the Ready 
Gel Tris-HCl Gel, 12% in Tris/glycine/SDS buffer. 
 
7.2.3. L-aspartate oxidase enzyme electrode 
Polyvinylimidazole (GFS Chemicals), ammonium hexachloroosmate (IV) (Sigma, and 
2,2’-dipyridine (TCI America) were used as received.  [Os(2,2’-bipyridine)2Cl2] and complexed 
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polymer PVI8-10-Os were synthesized using procedures reported in the literature (Forster & Vos, 
1990). 
The enzyme electrode was created by applying 5μL of an enzyme/polymer solution to a 
bare 1mm glassy carbon electrode.  The solution was formulated by mixing 6μL of 10mg/mL 
PVI-Os(bpy)2, 4μL of 5mg/mL L-aspartate oxidase, and 0.375μL 4mg/mL PEGDGE. 
 
7.2.4. L-aspartate oxidase Amplex Red fluorimetric enzyme assay 
The assay mixture contained phosphate buffered saline (PBS) (Mediatech), Amplex Red 
(Invitrogen), and horseradish peroxidase (Sigma). 
 
7.2.5. HPLC measurements of tyrosine 
For the quantification the tyrosine concentrations, cell-free culture supernatants were 
filtered through 0.2-µm-pore-size polytetrafluoroethylene membrane syringe filters (VWR 
International) and high-performance liquid chromatography (HPLC) analysis of the sample was 
performed with a Waters 2690 Separations module connected with a Waters 996 photodiode 
array for detection at a 278nm wavelength.  The samples were separated on a Waters Resolve 
C18 column using a mobile phase consisting of 0.1% (v/v) trifluoroacetic acid (TFA) in water 
(solvent A) and 0.1% (v/v) TFA in acetonitrile (solvent B).  The solvent gradient program 
utilized was: 95% solvent A and 5% solvent B at 0 min., 20% solvent A and 80% solvent B at 8 
min., 80% solvent A and 20% solvent B at 10 min., and 95% solvent A and 5% solvent B at 11 
min. 
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7.2.6. Bacterial strains and shake flask fermentation 
The tyrosine producing strain used in this study was the K12 T2 tyrosine overproducing 
strain which had the genotype Escherichia coli K12 ΔtyrR  pCL1920::PLtetO−1aroGfbrtyrAfbr 
ppsAtktA (Lutke-Eversloh & Stephanopoulos, 2007).  The aerobic fermentation was performed 
in 250mL Erlenmeyer flasks at 37ºC using an orbital shaker rotation speed of 225rpm.  The 
culture medium was MOPS-buffered minimal medium with 5g/L glucose and 2g/L NH4Cl as 
well as the antibiotics kanamycin and spectinomycin to maintain the plasmids (Neidhard.Fc, 
Bloch, & Smith, 1974).  To induce the Plac promoter, 2 mM IPTG was added. 
 
7.3. Enzyme electrodes 
Enzyme electrode technology is an analytical technique which has been popularized 
recently because of their use in glucose measurements for diabetes patients (Heller, 1999).  They 
also have high measurement sensitivity since they have the ability to measure metabolite 
concentrations in the micromolar range.  An enzyme electrode is a device which uses a 
combination of an enzyme and an electrode to measure the concentration of a target chemical.  
The electrical properties of the device, such as the current, change when the concentration varies.  
The enzyme also has specificity to the metabolite of interest.  One advantage of using enzyme 
electrodes is that they can be relatively fast compared to other analytical techniques like HPLC.  
Enzyme electrodes can be used in a cell culture system to measure more than one metabolite at a 
time continuously or semi-continuously without substantial complexity.  With this functionality, 
one could measure the product metabolite and glucose and then calculate the stoichiometric 
yield.  One could also preferentially choose mutants which produce a larger amount of product 
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during the exponential phase, the stationary phase, or at any particular time during the 
fermentation. 
There are several types of enzyme electrodes, and the main ones will be described here.  
The most basic electrode is one in which the enzyme is immobilized on the surface of the 
electrode by a non-conductive material such as a polymer.  The enzyme reacts with the 
metabolite of interest to produce a chemical which can be oxidized or reduced.  Thus, the loss or 
gain of electrodes can be detected by monitoring the current of the electrode. 
A second class is the conducting polymer enzyme electrode.  Conducting polymers can 
be electrodeposited to create a reproducible layer of polymer.  The enzymes are either entrapped 
in this polymer matrix or covalently bonded to the polymer.  The enzymes used in these 
electrodes are oxidoreductase enzymes.  Oxidoreductase enzymes catalyze redox reactions and 
produce hydrogen peroxide.  The hydrogen peroxide is then detected electrochemically.  One 
issue with this method is that the high reduction potentials needed for detection can also reduce 
other chemical species and increase the amount of interference in the measurement. 
Another class of enzyme electrodes is the mediator-modified carbon paste electrode.  In 
this technology, an oxidoreductase enzyme and a mediator are immobilized to a conductive 
carbon paste.  Most of the oxidoreductase enzymes contain cofactors which transfer electrons 
with the substrate.  Some cofactors are buried inside an insulating protein shell so few electrons 
move outside the enzyme.  As a result, a chemical species is needed to transfer the electrons 
from the cofactor to the electrode.  In this case, the mediator performs this function.  A 
disadvantage with this technique is that the mediator adds complexity and can solubilize which 
can decrease the amount of mediator available for transferring electrons (Mulchandani & Rogers, 
1993). 
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The last technology is the redox polymer enzyme electrode.  This technology has been 
shown to measure various metabolites including pyruvate, glutamic acid, and lactate at 
concentration levels as low as in the range of 0.3-2μM (Belay et al., 1999; Gajovic, Binyamin, 
Warsinke, Scheller, & Heller, 2000; Ohara, Rajagopalan, & Heller, 1994).  They have three 
principle components: an electrode, a redox polymer, and an enzyme.  Any standard electrode 
can be used such as a glassy carbon or gold electrode.  The redox polymer contains osmium 
(2+/3+) complex redox centers tethered to the main polymer chain as shown in Figure 7.1 
(Forster, Walsh, Mano, Mao, & Heller, 2004).  Like the previous two enzyme electrode types, 
oxidoreductase enzymes are used.  When the enzyme electrode comes in contact with the 
metabolite of interest, electrons are transferred to the cofactor associated with the enzyme.  The 
osmium redox centers make electrical contact with the cofactor and transfer the electrons to other 
redox centers and ultimately to the electrode.  Since the osmium centers are tethered to the 
polymer, they will not become soluble. 
 
Figure 7.1: Schematic of redox polymer enzyme electrode showing electron transfer from 
metabolite to the electrode 
 
Figure 7.2 has a more detailed description showing the path of the electrons through an enzyme 
electrode.  The redox potential of the polymer can be carefully tuned so that it is close to that of 
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the enzyme.  As a result, the potential used for sensing is large enough in absolute magnitude for 
the enzyme electrode to be active and to regenerate the enzyme.  However, it is also low enough 
that other chemical species are not reduced or oxidized which could generate interference.  Any 
oxidoreductase enzymes with a tightly bound cofactors such as FAD or heme can be used in this 
system. 
 
Figure 7.2: Diagram of electron transfer in an oxidase enzyme electrode (Belay et al., 1999) 
 
7.3.1. Tyrosine enzyme electrode 
Tyrosine enzyme electrodes using the simple enzyme immobilization technique were developed 
to increase their linear measurement range and to demonstrate their use in measuring cell culture 
samples.  Other groups have developed enzyme electrodes to detect different types of phenols by 
immobilizing tyrosinase using an agar gel matrix (Stanca, Popescu, & Oniciu, 2003).  The 
enzyme electrodes in this experiment were fabricated by immobilizing the mushroom tyrosinase 
enzyme onto an electrode with a poly(1-vinylimidazole) (PVI) polymer.  Figure 7.3 shows how 
this electrode detects tyrosine.  The immobilized tyrosinase enzyme reacts with tyrosine to form 
dopa and then dopaquinone.  Dopaquinone is electrochemically detected by applying a reducing 
potential to the electrode and measuring the current as the output.  This reducing potential 
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converts dopaquinone back to dopa which can then be reconverted back to dopaquinone.  Thus, 
multiple dopaquinone molecules can be detected from a single tyrosine molecule. 
 
 
Figure 7.3: Schematic of how tyrosine enzyme electrode detects the presence of tyrosine.  
Tyrosine is converted to dopa and dopaquinone by the tyrosinase enzyme.  Dopaquinone can be 
electrochemically detected 
 
As can be seen in Figure 7.4, the calibration curve of the unmodified tyrosine enzyme 
electrode has a linear detection range of 250μm.  However, E. coli tyrosine overproducing strains 
can increase the extracellular tyrosine levels up to 2.75mM.  Nafion films have been known to 
limit the diffusion of metabolites to the enzymes in an enzyme electrode (Zhu et al., 1994).  It 
was hypothesized that by adding a diffusion-limiting layer on top of the enzyme electrode, the 
linear range could be increased.  After performing measurements using electrodes with Nafion 
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films, it was determined that the measurement range was extended up to 1mM with one 0.5% 
(v/v) Nafion layer and up to 2.5mM with an additional 0.25% (v/v) Nafion layer (Figure 7.4). 
 
 
Figure 7.4: Tyrosine enzyme electrode calibration curves for plain enzyme electrodes and ones 
with 0.5% and 0.5+0.25% Nafion films 
 
Measuring cell culture solutions with high tyrosine concentrations degraded the enzyme 
electrodes, and enzyme electrodes without a Nafion film could be constructed more reliably.  As 
a result, unmodified tyrosine enzyme electrodes were used to measure 10× diluted cell culture 
supernatant samples from E. coli tyrosine overproducing strains.  Table 7.1 lists the samples used 
in this experiment.  Each sample was run in biological (e.g., shake flask) quadruplicate. 
Sample Culture Time (Hours) IPTG Added? 
1 8.5 Yes 
2 9.5 Yes 
3 10.5 Yes 
Table 7.1: Cell culture samples for tyrosine enzyme electrode measurements 
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There is a good linear correlation between the enzyme electrode measurements and those taken 
on an HPLC although there is a baseline shift in the absolute values of the two measurements 
(Figure 7.5).  The undiluted concentrations are reported in the graph. 
 
Figure 7.5: Comparison of cell culture supernatants from tyrosine overproducing strains 
measured with an HPLC and a tyrosine enzyme electrode 
 
These results demonstrate that the ability of these tyrosine enzyme electrodes to measure cell 
culture solutions although further work must be done to measure high tyrosine concentration 
samples without dilution.  These measurements were taken in Eppendorf tubes but extending the 
measurements to a 96 well plate format could be possible way to improve the throughput of the 
measurement. 
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7.3.2. L-aspartic acid enzyme electrode 
A redox enzyme electrode was built to measure L-aspartic acid concentrations.  Initially, 
an L-aspartate oxidase enzyme from E. coli was utilized, but that enzyme has a weakly bound 
FAD cofactor which can easily become unbound when placed in solution.  The P. horikoshii 
version of the enzyme has a tightly bound cofactor which makes it more suitable for use in an 
enzyme electrode (Sakuraba et al., 2002).  This enzyme electrode was fabricated by 
immobilizing the L-aspartate oxidase enzyme from P. horikoshii onto an electrode with a PVI-
Os(bpy)2 redox polymer.  Neither the enzyme nor the redox polymer was commercially available 
so they were both synthesized.  The purity and molecular weight of the enzyme was confirmed 
with SDS-Page.  The resulting gel showed that the product had high purity and the product was 
at the target molecular weight of 56.9 kDa (Figure 7.6).  Using the Bradford method, the protein 
concentration of the purified L-aspartate oxidase was determined to be 32.8 mg/mL.  An assay 
described by Sakuraba, et al. was used to quantify the L-aspartate oxidase enzymatic activity as 
0.028 U/mg @ 37ºC (Sakuraba et al., 2002). 
 
Figure 7.6: SDS-Page of P. horikoshii L-aspartate oxidase 
48.8kDa
64.2kDa
37.1kDa
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Once both the enzyme and redox polymer were synthesized, enzyme electrodes were 
created and tested using an applied voltage of +0.27V Ag/AgCl.  Figure 7.7 shows calibration 
curves for an electrode containing 75% PVI-Os(bpy)2 and 25% L-aspartate oxidase by weight.  
The measurements were performed at both 25ºC and 37ºC.  In both measurements, L-aspartic 
acid concentrations up to at 5mM could be measured, and the 37ºC measurement had the ability 
to detect up to 7mM without a decrease in the signal.  The measurement at 37ºC has a higher 
output, which was expected since the enzyme comes from a thermophilic bacterium which has 
an optimal growth temperature of 98ºC (Sakuraba et al., 2002). 
 
 
Figure 7.7: L-aspartic acid enzyme electrode calibration curve at 25ºC and 37ºC 
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7.4. L-asparate oxidase enzymatic assay 
The Amplex Red system can also be used to detect aspartic acid.  In this assay, the same 
P. horikoshii L-aspartate oxidase enzyme used in the enzyme electrode is a component of the 
reaction mixture along with HRP and Amplex Red.  The assay reaction is identical to the one 
previously described to detect xylose, glucose, and ethanol.  An L-aspartic acid molecule forms a 
fluorescent resorufin molecule through the following set of reactions: 
L-Aspartate Oxidase
2 2
HRP
2 2 2 (Fluorescent)
2
(Not Fluorescent)
L-Aspartic Acid + O  H O
H ResO + Amplex R orufined O
Iminoaspartate +→
→ +
 
In this assay, 50μL of the sample is added to a mixture containing 5μL 5U/mL L-aspartate 
oxidase, 1μL 2.89mM flavin adenine dinucleotide (FAD), and 50μL Amplex Red assay solution, 
which was composed of 100μM Amplex Red and 0.2U/mL HRP in PBS.  The following figure 
shows that the calibration curve is linear up to 100μM when the assay reaction occurs at 37ºC for 
30 minutes. 
 
Figure 7.8: L-aspartic acid fluorimetric enzymatic assay calibration curve 
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7.5. Conclusions 
A tyrosine enzyme electrode was developed to measure tyrosine solutions up to 2.5g/L 
through the use of a Nafion diffusion-limiting film.  Because of stability issues with the 
electrodes with the Nafion film, the tyrosine concentration of cell culture solutions was measured 
with enzyme electrodes without the film and by diluting of the culture samples.  The results from 
these measurements show a good correlation between the tyrosine enzyme electrode and HPLC 
measurements.  A redox enzyme electrode for measuring L-aspartic acid was fabricated using P. 
horikoshii L-aspartate oxidase and could measure concentrations up to 7mM.  In both enzyme 
electrode systems, the measured electrical current for each measurement needed at least two 
minutes to stabilize.  If 104 samples were to be measured with this system serially, the 
measurement time would be almost 2 weeks.  Thus, no further work was performed to 
incorporate it into a true high throughput screening platform.  Since the measurement time for 
the enzyme electrodes is less than that for an HPLC, they could be used in systems where lower 
throughput is sufficient or for periodic monitoring of a fermentation or cell culture system.  The 
L-aspartate oxidase was also incorporated into an Amplex Red assay system to measure L-
aspartic acid concentrations up to 100μM. 
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Chapter 8. CONCLUSIONS - RECOMENDATIONS 
 
 
 
 
8.1. Summary 
A flexible high throughput screening platform based on microfluidic emulsion 
technology has been developed to select for cells capable of high extracellular metabolite 
secretion or uptake.  Cells are encapsulated in aqueous droplets surrounded by an immiscible 
fluorinated oil phase.  After culturing the cells for a predetermined amount of time, chemicals for 
a fluorescent assay are incorporated with the cell-containing droplets to measure the extracellular 
metabolite concentration.  Droplets are subsequently sorted based on the fluorescence intensity 
which, in turn, correlates with the concentration of the assayed metabolite.  This screening 
platform has the ability to measure 104 clones in two to three hours and is flexible because the 
oxidase enzyme/HRP/Amplex UltraRed assay system can measure various metabolites by 
utilizing the appropriate oxidase enzyme.  Furthermore, this system is not limited to this specific 
assay system since any fluorescent assay can be incorporated.  This screening platform is the first 
to incorporate droplet coalescence, delay line, fluorescence detection, and sorting modules into a 
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single microfluidic device.  Although the microaerobic culturing step is performed simply with a 
capped syringe, the rest of the system consists entirely of microfluidic devices (Chapter 2). 
There is also an assay cost advantage of this screening methodology compared with 96 
well plate technology.  The droplets formed in these devices contain volumes of 0.3-3nL which 
is considerably smaller than the 50μL per well needed with 96 well plates.  As a result, the cost 
of the assay chemicals needed for high throughput screening is decreased dramatically.  To 
screen 104 clones for xylose detection, this microfluidic droplet system uses $4 of chemicals 
while for a 96 well plate system, the cost would be over $2000 (Section 2.5.6). 
This high throughput screening system was utilized to select for both high xylose and 
glucose consuming strains.  A high xylose consuming yeast strain was enriched by over 40,000× 
from an initial mixture containing 0.01% high xylose consuming cells and the balance from a 
low xylose consuming strain (Section 3.3.4).  Three S. cerevisiae libraries were screened with 
this system and strains which consumed more xylose than the controls were identified in each 
case.  One of these libraries was a genomic DNA library, which was constructed to determine the 
mutations introduced during the evolution of a strain which allowed it to consume xylose at a 
faster rate.  The best mutant selected from this library contained multiple copies of the Piromyces 
sp. E2 XYLA gene which codes for xylose isomerase, the first enzyme in the xylose utilization 
pathway (Section 3.3.7).  This screening system was also utilized to select for high glucose 
consuming yeast strains (Chapter 4) and high xylose consuming rpoA and rpoD E. coli libraries 
were screened (Chapter 5).  When growing the selected E. coli mutants in a bulk culture using 
rich medium, the rpoA mutants had slightly higher xylose consumption and ethanol production 
rates than the control while there were no improved mutants from the rpoD library.  However, 
when the selected strains from both libraries were cultured in a minimal medium similar to that 
CHAPTER 8: Conclusions 
  154  
used to culture cells in the screening system, almost all of the strains had significantly higher 
xylose consumption compared to the controls.  Direct measurement of ethanol production was 
also investigated, but it was determined that ethanol leaks out of the droplets because ethanol is 
slightly soluble in all oils tested (Chapter 6). 
While evaluating different measurement systems for their suitability to high throughput 
screening, several amino acid measurement technologies were developed.  An enzyme electrode 
for tyrosine was demonstrated to have the ability to measure diluted cell culture samples from a 
tyrosine overproducing strain.  This enzyme electrode was modified by adding a diffusion-
limiting Nafion film to increase the dynamic measurement range up to 2.5mM (Section 7.2.1).  
An L-aspartate redox enzyme electrode was created by using the P. horikoshii L-aspartate 
oxidase and could measure L-aspartic acid concentrations up to 7mM (Section 7.2.3).  A 
fluorimetric enzymatic assay for L-aspartic acid was also developed using this same enzyme in 
combination with the horseradish peroxidase and Amplex Red system to measure concentrations 
up to 100μM (Section 7.2.4). 
 
8.2. Conclusions 
Combinatorial approaches to metabolic engineering are important tools for developing 
industrial strains because they can identify genomic loci whose modulation improves the 
production phenotype.  Such loci are inaccessible by using traditional methods.  While many 
methods exist for creating libraries, suitable screening/selection methods are the limiting factor.  
Selecting for desirable phenotypes based on the extracellular metabolite concentrations is 
critical.  Many product metabolites are secreted by cells and measuring the consumption of 
medium components is also important.  However, it is a challenging endeavor to develop such a 
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selection method.  Previous screening systems do not have sufficient throughput or were 
developed to be very specific to the phenotype of interest so they cannot be easily modified for 
other applications.  The high throughput screening system described in this thesis can select for 
cells based on any metabolite which has a corresponding fluorescent assay, and several 
applications have been demonstrated.  This powerful tool can enable the discovery and the 
engineering of improved strains for the overproduction of fuels, chemicals, and pharmaceuticals. 
 
The following conclusions can be made based on the work from this thesis: 
• Fluorescent assay technology is compatible with a high throughput screening system. 
• Microfluidic droplet technology is a suitable platform for developing a high throughput 
screening system. 
• A single microfluidic device can contain droplet coalescence, delay lines, fluorescence 
detection, and sorting modules. 
• The high throughput screening system described in this thesis can be used to identify high 
xylose and glucose consuming strains. 
• S. cerevisiae and E. coli organisms can be cultured in this system. 
• Microfluidic droplet technology has assay cost advantages over 96 well plate technology. 
• The biological diversity of a population can be characterized with this system by analyzing 
the fluorescence distribution of the droplets containing cells from this population. 
• Using combinatorial approaches for metabolic engineering with a suitable screening system 
allows for the identification of strains with better phenotypes or the characterization of 
strains, such as the identification of mutations from an evolved strain, which otherwise could 
not be performed with other techniques. 
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• Enzyme electrodes can be developed to measure various amino acids although they are not 
suitable for high throughput screening. 
 
8.3. Future work 
Xylose and glucose consumption by cells was studied, but the system can be extended to 
detect the consumption or production of other metabolites.  These other metabolites could be 
measured through the simple substitution of the appropriate oxidase enzyme which catalyzes a 
reaction with the metabolite of interest.  High producing lactic and succinic acid bacterial strains 
could be selected from a library (Patnaik et al., 2002; Zeikus, Jain, & Elankovan, 1999).  If the 
ethanol leakage issue could be solved, this would be a powerful system to select for high 
producing ethanol strains.  The applications of this system could also be broadened to other 
organisms, such as culturing mammalian cells grown in suspension, or the production of other 
secreted molecules such as proteins (Browne & Al-Rubeai, 2007). 
Libraries with sizes of 105 or higher could be screened by optimizing the microfluidic 
device which coalesces, detects, and sorts droplets.  This device is the throughput bottleneck 
since the current device design can only sort 104 droplets in two to three hours while the droplet 
production rate for the cell encapsulation device is 106 droplets in the same amount of time.  The 
major limitation of the sorting device is that the droplets cannot be reinjected and produced at 
high rates because if droplets are too close together when they reach the sorter, more droplets 
will flow unintentionally into the “desired” channel which would increase the false positive error 
rate.  One way to increase the droplet production rate while maintaining the current droplet 
spacing is to decrease the droplet size.  The current droplet sizes were chosen to be compatible 
with a channel thickness which minimizes the back pressure in the delay lines.  If the assay 
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reaction rate could be increased, the channel height could be decreased without exacerbating the 
back pressure problem.  Since there is an excess of assay droplets compared with the number of 
reinjected droplets, there are two droplet size populations after the coalescence device, 
uncoalesced assay droplets and coalesced assay plus reinjected droplets.  The smaller droplets 
have higher linear velocity than the large ones which effectively reduces the spacing.  Thus, the 
initial droplet spacing increased even further to ensure that the number of false positives is 
minimized.  The throughput of the device could be increased if a coalescence mechanism could 
be developed in which there is an exact ratio of reinjected and assay droplets. 
The system as described uses microaerobic culturing in a capped syringe.  To culture 
aerobically, a different system must be developed which would allow for extra oxygen to reach 
the cells.  A microfluidic culturing system could be developed for this application since PDMS 
has a high oxygen permeability and fluorinated oils have high oxygen solubility (Lowe, 2002; 
Shiku et al., 2006).  Furthermore, microfluidic channel heights are small which is beneficial for 
oxygen transfer through the oil.  Two possible culturing systems could be created.  The most 
ideal system would be one where the cells in droplets are cultured while they travel through a 
long series of delay lines.  In this design, the contents of the droplets would be mixed as they 
move through the channels which would prevent the clumping of cells.  A second but simpler 
design would be one where a microfluidic reservoir collects the droplets and the cells are 
cultured statically.  In both systems, the droplets containing cells would be incubated for the 
proper amount of time in an incubator or on a hot plate and then reinjected into the current 
coalescence and sorting device. 
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Chapter 9. APPENDIX 
9.1. High throughput screening system 
9.1.1. Incoming yeast cell density for 1 cell in 2-3 droplets 
Strain OD600 for 1 Cell in 2-3 Droplets 
H131 and TAL1 Strains 0.075 
BY4741 0.1 
ATCC 24858 0.12 
Table 9.1: Incoming cell densities for 1 cell in 2-3 droplets 
 
9.1.2. Fluorescence data 
The existence of empty droplets allowed for all cell culture fluorescence data to be 
normalized by the average fluorescence value of the high fluorescence empty droplet since they 
contained a known concentration of the sugar of interest.  The empty droplet fluorescence was 
normalized to an average value of 1.  To properly compare fluorescence data from different 
experiments, the number of droplets was normalized so that the total number was 5000. 
 
9.1.3. Sorting device error quantification 
There are two types of general errors from the sorting system: false negatives and 
positives.  The number of false negatives is essentially zero because the system is designed to 
ensure that all sorted droplets are pulled electrophoretically by the sorting electrodes.  False 
positives are caused by droplets which should flow into the undesired channel but flow into the 
desired channel because the pressure differential between the channels is not sufficiently high or 
because droplets are too close together as they approach the sorting area of the device.  Equation 
9.1 quantifies the false positive sorting error using data from the enrichment experiments.  The 
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good droplets contain cells from the desired strain and the bad droplets have the undesired strain 
cells. 
( )
( )GB
Gz x y Gz
A
Bz x y Bz
+ − =+ −  Equation 9.1 
Where:  
• x is the false positive error rate as defined as the % of droplets which randomly go into the 
“good” channel 
• y is the % of incoming good (G) or bad (B) droplets (out of total number of droplets) 
• z is the % of droplets intentionally sorted 
• G is the % of good droplets intentionally sorted (out of the total number of intentionally 
sorted droplets) 
• B is the % of bad droplets intentionally sorted (out of the total number of intentionally sorted 
droplets) 
• A is the actual enrichment of good vs. bad 
 
In these calculations, the intentional sorting rate and random error rate are assumed to be 
independent.  The theoretical enrichment was assumed to be constant even if the incoming good 
to bad concentration ratio varied which should be a good assumption because the theoretical 
value was based on the individual strain data and not on a mixture.  Furthermore, growth 
contributions from the screening system (e.g., cell growth in droplet) were included in the 
calculations. 
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Experiment False Positive Error Rate 
1:1 H131/TAL1 Enrichment (Bin < 0.6) 2.4% 
1:1 H131/TAL1 Enrichment (Bin < 0.7) 2.6% 
1:1 ATCC 24858/BY4741 PDC1-GFP 
Enrichment (Bin < 0.4) 6.4% 
1:1 BY4741 PDC1-GFP/BY4741 Δadh1 
Enrichment (Bin < 0.4) 15.4% 
1:1 BY4741 PDC1-GFP/BY4741 Δadh1 
Enrichment (Bin < 0.4) 20.4% 
Table 9.2: False positive error rate from enrichment experiments 
 
9.1.4. Mixing time in delay lines 
Ensuring proper mixing of the coalesced droplets is important for the accuracy and 
repeatability of the fluorescent assay measurement.  Mixing of droplets in straight channels 
occurs in a manner where each half of a droplet is mixed separately by convection (Handique & 
Burns, 2001).  The calculation of the mixing time depends on whether the system is convection 
or diffusion limited.  Before quantifying the convection and diffusion time scales, several 
parameters must be defined.  The diameter of the droplet L is 250μm and height of the channels 
d is 75μm.  Diffusion constant D is estimated to be 6.86×10-6 cm2/sec, the total volumetric flow 
rate Q = 1230μL/hr = 1230×10-6 dm3/hr = 1230×109 μm3/hr, and the cross sectional area A = 
100μm × 300μm = 30000μm2 (Longsworth, 1952).  Using the flow rate and area values, the 
linear velocity of the droplet is calculated to be Vd = Q/A = 4.13 ×107 μm/hr = 11,472 μm/sec.  
The calculations of the time scale equations are shown below: 
250~ 0.022sec
11,472 / sec
μ
μ= =conv d
L mt
V m  Equation 9.2 
( )
( )2
22
2 2 6 cm
sec
75
~ 0.83sec
6.86 10  
μ
π π −= =×diff
mdt
D
 Equation 9.3
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Since tdiff >> tconv, the following equation can be used to calculate the total mixing time needed 
for a drop to become 90% mixed: 
23 0.008 0.131sec= + =mix
d
L dt
V D  Equation 9.4 
The delay line is 0.4m long so the total delay line time is 30 seconds which is several orders of 
magnitude longer than the mixing time.  Furthermore, there are two right angle turns and ten U-
turns which cause chaotic mixing within the droplet.  These sharp turns increase the mixing 
speed and also allows for the two halves of the droplet to mix (Bringer, Gerdts, Song, Tice, & 
Ismagilov, 2004). 
 
9.1.5. Data filtering on detection data 
This section describes how the fluorescence data was filtered.  The purpose of the 
filtering is to ensure that only “true” data is being analyzed.  Two parameters are used to filter 
out the data: the size of the droplets and the amount of fluorescence.  The detection tool 
measures the size as the width of the fluorescence peak in milliseconds.  Figure 9.1 shows a plot 
of droplet size vs. fluorescence.  The red rectangle contains the filtered data.  Filtering by size 
ensures that the analyzed population contains droplets with a tight size distribution.  The large 
droplets with expected fluorescence values are due to unintentional droplet coalescence either 
during droplet collection, culturing, or reinjection.  The very small droplet sizes are not actual 
droplets but are artifacts from the fluorescence detection software.  The cluster with fluorescence 
values between 1.75 and 2.5 are the droplets which contain the initial glucose concentration in 
the medium.  Thus, fluorescence values above 2.5 are not included because these data points are 
caused when an assay droplet coalesces with two reinjected droplets to produce a high 
fluorescent signal.  Only screening by droplet size would not be sufficient to filter these droplets 
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because the reinjected droplets are small and may not affect the combined droplet size by a 
significant amount. 
 
Figure 9.1: Fluorescence detection data filtering.  The red rectangle surrounds the droplets 
which are actually analyzed by the detection/sorting system.  The droplets outside of the 
rectangle are filtered out by the LabView software program. 
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9.1.6. Picture of Microfluidic Setup 
 
Figure 9.2: Microfluidic setup with microscope, syringe pumps, 
power supply for coalescence, laser, and PMT 
 
9.2. Yeast xylose consumption 
9.2.1. Sorting data from xylose enrichment/library screening experiments 
Enrichment of 1:1 H131/TAL1 Ratio 
Bins Sorted Sorted Droplets Total Droplets Percentage Droplets Sorted 
0-0.6 425 9466 4.49% 
0-0.7 977 10,677 9.19% 
 
Enrichment of Low H131/TAL1 Ratio 
46.5hr culture 
H131/TAL1 Ratio Sorted Droplets Total Droplets Percentage Droplets Sorted 
1:1000 579 8906 6.50% 
1:10,000 1st Round 299 10,601 2.82% 
1:10,000 2nd Round 751 4087 18.4% 
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Xylose Transporter Gene Shuffling Library: 
1st round: 45.5hr culture, 2nd round: 43.7hr culture, and 5 clones picked after 2nd round. 
Round of Screening 
(Bin Sorted) 
Sorted Droplets Total Droplets Percentage Droplets Sorted 
1st 
(<0.28) 478 9281 5.15% 
2nd 
(<0.26) 403 14,715 2.47% 
 
Xylose Consumption Library 
1st round: 45.5hr culture, 2nd round: 41hr culture, and 5 clones picked after 2nd round. 
Round of Screening 
(Bin Sorted) 
Sorted Droplets Total Droplets Percentage Droplets Sorted 
1st 
(<0.32) 507 6365 7.97% 
2nd 
(<0.32) 303 7463 4.06% 
 
Genomic DNA Library 
1st round: 70.5hr culture 
Bin Sorted Sorted Droplets Total Droplets Percentage Droplets Sorted 
0.78-0.90 85 1089 7.81% 
 
rpoA Library 
1st round: 60.5hr culture 
Bin Sorted Sorted Droplets Total Droplets Percentage Droplets Sorted 
< 0.86 518 3663 14.2% 
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rpoD Library 
1st round: 60.5hr culture 
Bin Sorted Sorted Droplets Total Droplets Percentage Droplets Sorted 
< 0.67 247 9446 2.61% 
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